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1. Abbreviations 
aa amino acid
AMD age-related macular degeneration
APP Amyloid precursor protein
bHLH basic helix–loop–helix
BMP bone morphogenetic protein
BOR branchiootorenal dysplasia
BSA Bovine serum albumine
cDNA complementary deoxyribonucleic acid
dach dachshund
DNA deoxyribonucleic acid
DSL Delta, Serrate, Lag-2
E(spl) Enhancer of split locus
EFEMP1 EGF-containing fibrillin-like extracellular matrix protein 1
EFEMP2 EGF-containing fibrillin-like extracellular matrix protein 2
EGF epidermal growth factor
ey eyeless
eya eyes absent
eyg eye gone
GFP green fluorescent protein
GMR Glass Multimer Reporter
gro groucho
GST Glutathione-S-transferase
hh hedgehog
HRP Horseradish peroxidase
lz lozenge
MF Morphogenetic furrow
ML Malattia Leventinese
NIC Notch intracellular
ninaE neither inactivation nor afterpotential E
Pax paired box
PBS phosphate-buffered saline
PCR Polymerase chain reaction
RGC retinal ganglion cell
RPE retinal pigment epithelium
RT room temperature
S35 HN-1EC S35 labeled extracellular part of human Notch-1
SDS sodium dodecyl sulfate
Six sine oculis homeobox
smo smoothened
so sine oculis
soAE sine oculis autoregulatory element
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Su(H) Suppressor of Hairless
TGF-? transforming growth factor-?
toy twin of eyeless
w white
wt wildtype
y yellow
?-Gal ?-Galactosidase
The introduction as well as the results presented in 2 (The leventina gene as a model
system to study human macular degeneration in Drosophila), subtitles 2.4.1 - 2.4.10 
were used in the framework of the MD-PhD program of the university of Basel to 
obtain the degree of Doctor from the Medical Faculty.
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2. The leventina gene as a model system to study 
human macular degeneration in Drosophila
2.1. Summary
Age-related macular degeneration (AMD) is one of the most frequent reasons for 
blindness of the elderly people and accounts for approximately 50% of registered 
blindness in the industrial world. AMD pathogenesis is poorly understood and there is 
no beneficial medical or surgical treatment possible in most cases. 
The autosomal dominant retinal disease Malattia Leventinese (ML) has a similar
phenotype to AMD and seems to be an early onset form. It has recently been shown 
that ML is caused by a single point mutation (Arg345Trp) that affects the extracellular
matrix protein EFEMP1. 
Studying the molecular function of EFEMP1 could therefore be helpful to understand 
the pathomechanism of both, ML and AMD. 
In the last decade striking homologies between Drosophila and vertebrate eye
development have been revealed. In addition, the fly model was useful to gain insight
into the molecular mechanisms that lead to neurodegenerative diseases like Alzheimer,
Parkinson and Chorea Huntington. 
In this thesis, Drosophila melanogaster was used as a model system in an attempt to 
reveal the function of EFEMP1 and its putative Drosophila homologue the leventina
gene, in the molecular mechanisms of eye development and its function in the retina of
adult flies.
Pax-6, the master control gene of eye development, is able to induce ectopic eyes in 
Drosophila and ectopic eye structures in vertebrates. In the ribbonworm Lineus
(Nemertini) Pax-6 is also important for regeneration and maintenance of the retina. 
This is in agreement with our working hypothesis that Pax-6 is involved in 
maintenance and regeneration of the human retina. 
The transmembrane receptor Notch genetically lies upstream of Pax-6. The Notch 
signaling cascade appears in many steps of eye development in human, mouse and 
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Drosophila. Activation of Notch increases the expression of the transcription factor
Pax-6 in frogs. 
EFEMP1 displays a high amino acid similarity to the ligands of the Notch receptor.
The point mutation in EFEMP1 that causes ML could result in a loss of its ability to 
activate the Notch signaling cascade leading to a inappropriate Pax-6 transcription and 
therefore cause ML. Based on this hypothesis one of our approaches was to test 
whether EFEMP1 interacts with Notch. If this is the case, EFEMP1 as a soluble Notch
ligand could be a therapeutic tool to activate Notch, increase the transcription of Pax-6
and thereby slow down retinal degeneration. 
With the so far used methods we were not able to get any evidence that EFEMP1 is 
indeed a Notch ligand despite the convincing sequence homology to known Notch
ligands.?
By overexpressing EFEMP1 and lvt, its putative fly homologue, in different 
developmental stages in Drosophila we could not detect any specific phenotypic
alteration. Overexpressing the mutated form of EFEMP1 that causes Malattia 
Leventinese did not show any mutant phenotype in the fly nor did it cause
degeneration of photoreceptor cells in the retina of aging flies.
Even though we do not have any evidence whether we can use the fly as a model
system to study the function of EFEMP1, the powerful genetics and the high 
conservation of the genetic regulatory network between vertebrate and Drosophila eye 
development makes it clear, that Drosophila is a very attractive in vivo system to study 
molecular mechanisms that lead to human diseases.
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2.2. Introduction
2.2.1. Malattia Leventinese
Malattia leventinese (ML) is a rare, autosomal-dominant retinal dystrophy that was
first described in patients living in the Leventina Valley in southern Switzerland, 
hence, its name. Clinically, patients usually present with slow, progressive visual loss, 
typically in the third decade of life. The fundi of affected individuals are characterized 
by the presence of yellow/white deposits of extracellular debris (drusen) arranged in a 
spoke-wheel or radial distribution centered on the fovea (Figure 2.1). Recently, the
gene responsible for this disorder was identified as the EFEMP1 gene (Stone et al., 
1999) encoding a fibrillin-like, extracelllular matrix protein.
The importance of Malattia Leventinese is due in large part to their close phenotypic
similarity to age-related macular degeneration (AMD), a disorder with a strong genetic
component that accounts for approximately 50% of registered blindness in the Western
world. AMD pathogenesis is poorly understood and there is no beneficial medical or
surgical treatment possible in most cases (Bressler et al., 1988). 
Just as in ML, the early hallmark of AMD is the presence of Drusen (Figure 2.1). 
Drusen are yellow/white hyaline deposits of extracellular debris consisting mostly out 
of lipids and proteins - but not EFEMP1 - and are located between the retinal pigment
epithelium (RPE) and the Bruch membrane.
Besides the similar distribution of drusen, the pattern of EFEMP1 accumulation in ML 
and AMD is analogous. In ML, EFEMP1Arg345Trp is not properly secreted from the
retinal pigment epithelium (RPE) and accumulates in the cytoplasma of the RPE and 
underneath the RPE overlaying the drusen. In patients with AMD, the normal form of 
EFEMP1 is secreted properly but accumulates at the same localization underneath the 
RPE (Marmorstein et al., 2002). Therefore it is suggestive that ML is an early onset 
form of AMD.
Studying EFEMP1 could  be important to get insights into the molecular mechanisms
that lead to ML and hence to AMD and possibly give some new ideas for the design of 
a treatment.
11
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Figure 2.1 Phenotypic comparison of ML and
AMD
A Fundus of a normal human eye 
B Fundus of a patient affected with Malattia
Leventinese (ML). The yellow drusen in the area
of the macula are the characteristic of ML.
C Fundus of a patient with age related macular
degeneration (AMD). Like in ML the center of the
retina is characterized by the presence of drusen
(arrow).
A and C from (Lang, 1998), B from (Stone et al.,
1999)
a)
A
B C
c)
2.2.2. EFEMP1 
The human protein EFEMP1 (also called fibulin-3 or S1-5) is a 490 amino acids (54 
kDa) extracellular matrix protein with a signal peptide at its amino terminal end and 9 
EGF like repeats. The gene spans approximately 18kb of genomic DNA, consists of 12
exons and is located on chromosome 2p16 (Ikegawa et al., 1996). 
EFEMP1 was originally isolated from a subtractively enriched cDNA library 
established from a subject with Werner syndrome (WS), a disease of premature aging 
(Lecka-Czernik et al., 1995). Microinjection of EFEMP1 mRNA into human 
fribroblasts is followed by the stimulation of DNA synthesis in a autocrine and
paracrine manner (Lecka-Czernik et al., 1995).
mRNA from EFEMP1 is found in various human tissues (Lung, ovary, small intestine, 
colon) except for the brain and the peripheral leukocytes (Ikegawa et al., 1996). In the
human eye, EFEMP1 is secreted by the retinal pigment epithelium and is localized to
the outer retinal segment, surrounding the photoreceptor cells. In patients with ML 
EFEMP1Arg345Trp is found in the tissue closest to the site of drusen formation (but not 
12
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in the drusen) (Stone et al., 1999) and gets accumulated in and underneath the retinal 
pigment epithelium.
The type of EGF-like domain present in EFEMP1 shows high homology to EGF-like
domains in several previously described proteins. These include the transforming 
growth factor ???binding protein (Kanzaki et al., 1990), a variety of extracellular
matrix proteins such as fibulin (Argraves et al., 1990), fibrillin (Maslen et al., 1991)
and nidogen (Mann et al., 1989), specific proteins involved in the blood coagulation 
cascade (protein S, factor IX) (Furie and Furie, 1988) and the transmembrane receptor
Notch and its ligands Delta and Serrate. All of these proteins are secreted to the 
extracellular space or bind to the plasma membrane, where they interact with other
proteins. The importance of the EGF repeats is due to their role in specific protein-
protein interactions. Indeed, point mutations in EGF repeats of fibrillin and factor IX
cause severe diseases like Marfan syndrom (Dietz et al., 1992; Hewett et al., 1993) and 
a distinct kind of hemophilia (Handford et al., 1991).
Similar to these diseases, a single exchange of an amino acid in the last EGF repeat of
EFEMP1 (Arg345Trp) leads to the retinal dystrophy Malattia Leventinese (ML) (Stone 
et al., 1999). 
The interaction of Notch with its ligands is also mediated by specific EGF repeats 
(Rebay et al., 1991). The EGF domains 11 and 12 of Notch specifically interact with 
the DSL domain of its ligands. This DSL domain is related to EGF repeats (Tax et al.,
1994). From our studies, EFEMP1 contains a putative DSL domain at its 
aminoterminal end. 
EFEMP1, which contains a signal peptide, 5 EGF domains and is able to stimulate
DNA synthesis via autocrine and paracrine modes, would appear, therefore, to be an
extracellular factor involved in cell proliferation. In addition, its role in the eye disease 
ML, its structural similarity to Notch ligands, its putative DSL domain and the fact that
Notch is important in eye development as explained below makes it conceivable that 
EFEMP1 acts on the retina by modulating the Notch receptor. 
2.2.3. The Notch receptor
Notch signaling is an evolutionarily conserved mechanism that is used in organisms
ranging from Drosophila to humans to control cell fates through local cell-cell 
13
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interactions. Signals transmitted through the Notch receptor, in combination with other 
cellular factors, influence differentiation, proliferation, and apoptotic events at all 
stages of development. Notch signaling modulates the ability on non-terminally
differentiated cells to respond to differentiation and proliferation signals in order to 
progress into the next developmental stage. Activation of Notch in immature precursor
cells suppresses their differentiation and delays cell fate specification. 
The Notch gene, first characterized in Drosophila melanogaster, encodes a 300-kD 
single-pass transmembrane receptor. The large extracellular domain contains 36
tandem EGF–like repeats and 3 cysteine-rich Notch/LIN-12 repeats. Six tandem 
ankyrin repeats, a glutamine-rich domain (opa), and a PEST sequence are found within 
the intracellular domain (Wharton et al., 1985). Notch-like proteins have been 
identified and extensively characterized in Caenorhabditis elegans (LIN-12 and GLP-
1) (Kimble and Simpson, 1997; Greenwald, 1998) sea urchins, and many different
vertebrates, including humans (Gridley, 1997; Sherwood and McClay, 1997). In all
animal models tested, mutations in the Notch receptor invariably result in
developmental abnormalities. In human, three disorders including a neoplasia (a T-cell
acute lymphoblastic leukemia/lymphoma), a late onset neurological disease 
(CADASIL) and a developmental disorder (the Alagille syndrome) are associated with 
mutations in the Notch1, Notch3 and Jagged1 (the vertebrate homologue of Serrate)
genes (Li et al., 1997; Joutel and Tournier-Lasserve, 1998).
In Drosophila, the two single-pass transmembrane proteins, Delta and Serrate, have
been identified as partially redundant Notch ligands (Delta and Jagged in vertebrates, 
LAG-2 and APX-1 in C. elegans) (Gu et al., 1995; Gridley, 1997; Greenwald, 1998). 
The transcription factor Suppressor of Hairless [Su(H)] (CBF1/RJBk in mammals,
LAG-1 in C. elegans) appears to function as the major downstream effector of Notch 
signaling and the genes of the Enhancer of split [E(spl)] locus, which encode nuclear 
basic helix-loop-helix (bHLH) proteins, are primary targets of Notch signaling (Egan 
et al., 1998; Greenwald, 1998). 
Activation of the Notch receptor requires at least three proteolytic cleavages 
(Weinmaster, 2000). The first cleavage of the Notch receptor occurs during
intracellular trafficking at the prospective extracellular side by a furin-like convertase. 
After this primary cleavage the receptor is presented as a heterodimeric transmembrane
protein (Blaumueller et al., 1997; Logeat et al., 1998). Interaction with a ligand 
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induces a second extracellular cleavage, close to the plasma membrane (Brou et al.,
2000) which, in turn, leads to a third cleavage in the transmembrane region that 
releases the intracellular part of Notch (NotchIC) from the membrane (Kopan et al.,
1996). NotchIC translocates to the nucleus where it acts in conjunction with the DNA-
binding protein Su(H). On its own, Su(H) acts as a transcriptional repressor whereas 
together with NotchIC Su(H) turns into a transcriptional activator (Furriols and Bray,
2001) and drives expression of downstream target genes like the genes from the E(spl)
complex.
In Drosophila, expression of a dominant activated form of the Notch receptor 
comprising only its intracellular part under the control of an eye specific enhancer
leads to a huge overproliferation of eye tissue. Conversely expression of a dominant
repressor of Notch signaling during eye development produces flies without eyes (Sun
and Artavanis-Tsakonas, 1997; Kurata et al., 2000). 
In vertebrates, retinal progenitor cells (RPCs) seem to be retained in a progenitor state
by the action of Notch-Delta signaling (Tomita et al., 1996; Henrique et al., 1997).
Together with other extrinsic signals, Notch signaling triggers retinal differentiation in 
Drosophila and vertebrates (Dorsky et al., 1997).
Notch acts upstream of Pax-6 and is able to induce ectopic retinal tissue (Kurata et al.,
2000; Kumar and Moses, 2001; Onuma et al., 2002). 
It is thinkable that the action of the Notch receptor is required for both, retaining RPCs 
in their undifferentiated state and, together with other extrinsic signals, trigger the
differentiation of RPCs into retinal cells by activating the transcription of Pax-6 and
other retinal specifications genes. Therefore, a soluble Notch ligand that acts as an
activator of Notch signaling could be a powerful tool to prevent retinal degeneration. 
2.2.4. Pax-6 
The Pax-6 gene was first cloned from mouse (Walther and Gruss, 1991). Since then,
Pax-6 genes have been cloned from representatives species of eight animal phyla,
including homologs of human (Ton et al., 1991) and Drosophila (Quiring et al., 1994a; 
Czerny et al., 1999).
15
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Pax-6 genes encode a transcription factor with two DNA binding domains, a
homeodomain and a paired domain, both of which have been highly conserved during 
evolution. In mammals, congenital diseases known as Aniridia (humans) and Small eye
(mice and rats) are caused by loss-of-function mutations of Pax-6 in heterozygotes,
whereas homozygous embryos lack eyes and nostrils completely, have brain and spinal 
cord malformations, and die prior to birth (Hill et al., 1991). In Drosophila, loss-of-
function mutations in the eyeless (ey) locus, found to encode a Pax-6 homologous gene 
(Quiring et al., 1994a), also show hypomorphic eye defects. In gain-of-function 
Drosophila mutants, ectopic eyes are formed on the antennae, legs, wings and halteres 
of the fly (Halder et al., 1995). Due to the fact that ectopic expression of Pax-6
homologs from human, mouse, squid and sea squirts (ascidians) are capable of 
inducing ectopic eyes in Drosophila (Halder et al., 1995; Glardon et al., 1997; 
Tomarev et al., 1997) and conversely, eyeless and twin of eyeless (the two Drosophila
homologs of Pax-6) are able to induce ectopic eye structures in Xenopus (Onuma et 
al., 2002), it was proposed that Pax-6 may serve as a universal master control gene for
eye morphogenesis in metazoa (Gehring and Ikeo, 1999).
In addition it has been demonstrated that Pax-6 has not only a function during 
development of the eye but also for its maintenance and regeneration: In the
ribbonworm Lineus sanguineus, injection of Pax-6 double-stranded RNA (RNAi)
which impedes translation of Pax-6 leads to the disappearance of the eyes, whereas the 
eyes reappear by giving the worm time to recover without any new injections of RNAi
(M.Tarpin, pers.comm.).
In vertebrates, Pax-6 is required for the development of the lens and the retinal
primordia (Glaser et al., 1994; Grindley et al., 1995; Ashery-Padan et al., 2000;
Collinson et al., 2000). 
In the retina of vertebrates Pax-6 mediates the full retinogenic potential of retinal 
progenitor cells (RPC) by directly controlling the transition from uncommitted RPC 
toward a lineage-restricted RPC intermediate. RPCs from mice, where Pax-6 is
conditionally knocked-out, lack the ability to differentiate into all of the 6 different cell
types present in a normal retina except for amacrine cells (Marquardt et al., 2001). 
In the retina of adult humans and mice Pax-6 and Notch-1 are still expressed
(F.Hafezi, pers. comm.). This is in perfect agreement with our working hypothesis 
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which is, that Notch-1 and Pax-6 are important for the maintenance and regeneration 
of the retina in the adult, Notch controls Pax-6, and the reason for retinal degeneration 
could be a decrease in Notch activity leading to a reduced transcription of Pax-6.
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2.2.5. Eye development in Drosophila and vertebrates 
The compound eye of Drosophila consists of approximately 800 single units - the 
ommatidia - that form a highly regular hexagonal array (Wolff and Ready, 1993). Each 
ommatidium, being somehow an eye of its own, consists of a lens, secreted by the cone 
cells, eight photoreceptor cells and pigment cells that surround the light gathering 
rhabdomers of the photoreceptor cells (Figure 2.2).
The Drosophila retina, which gives rise to the compound eye, is derived from the eye-
antennal imaginal disc (Figure 2.2). This monolayer epithelium is formed by an 
involution from the head ectoderm during embryonic stages. In the third larval stage
(the last before pupation) a wave of differentiation, the morphogenetic furrow, moves
from posterior to anterior across the eye imaginal disc. This wave, visible as an 
intendation in the imaginal disc, transforms the unpatternd and undifferentiated cells in 
front of the furrow into a precise pattern of determined and differentiated cells behind
the furrow. Hence, the undifferentiated eye imaginal disc develops into the compound
eye during pupation. 
The above described compound eye is from a morphological point of view completely
different from the camera type eye of vertebrates. The vertebrate eye consists of a light 
focusing system including the cornea, iris and lens that projects the incoming light on 
the neuroretina which is optically isolated from the surroundings by the retinal 
pigmentepithelium (RPE). 
The development of the vertebrate eye starts as a protrusion of the diencephalon 
(forebrain) in the middle of the fourth week of pregnancy resulting in a blister called
the optic vesicle. Through mutual interaction of this optical vesicle with the lens 
placode of the overlaying head ectoderm, the lens placode starts to invaginate, forming
the lens vesicle. At the same time when the lens is formed, the outer surface of the 
optic vesicle invaginates and forms the optic cup where the outer layer will become the 
RPE and the inner surface gives raise to the neural retina (Figure 2.2). 
18
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Figure 2.2 Drosophila and
vertebrate eye developmentA
A Eye-antennal imaginal disc
Schematic view of a larval eye-
antennal imaginal disc which gives
raise to the eye and the antenna of
the adult fly during pupation.
Differentiation occurs in a wave like
manner form posterior to anterior
across the disc leaving behind a 
precisely formed pattern, the 
ommatidia.
B An ommatidium of the adult fly
Longitudinal section through one of
the 800 ommatidia of the compound
eye of an adult fly.B
The cornea is secreted by the cone
cells. The rhabdomers are the light 
gathering parts of the photoreceptor
cells (R1-R8).
Both pictures are from (Kumar,
2001)
C Development of the vertebrate
eye
(A) The optic vesicle, a protuberance
of the forebrain (diencephalon),
extends towards the surface
ectoderm. The lens placode (the
prospective lens) appears as a local 
thickening of the surface ectoderm
near the optic vesicle. 
(B) The optic vesicle becomes an
optic cup.
(C) The lens placode invaginates and 
forms the lens vesicle while the two
layers of the optic cup become
distinguished as neuroretina and
RPE.
(D) The lens vesicle induces the 
development of the cornea.
(E) Cross-section through the
developed vertebrate eye
From (Cvekl and Piatigorsky, 1996)
C
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2.2.6. Homologies between human and Drosophila eye 
development
In spite of the different appearance of the compound eye and the camera type eye, 
several studies revealed astonishing homologies between Drosophila and human 
considering the molecular mechanisms of early eye development.
As mentioned above, the Notch receptor and the transcription factor Pax-6 are crucial 
for eye development in both species. In addition, a set of seven nuclear factors have 
been identified in Drosophila that are implicated in a highly conserved network that
directs the initiation of eye development (Halder et al., 1995; Oliver and Gruss, 1997; 
Gehring and Ikeo, 1999).
These ‘eye-specification genes’ (eyeless (ey), twin of eyeless (toy), sine oculis (so),
eyes absent (eya), dachshund (dac), eye gone (eyg) and optix) have all homologues
genes in vertebrates where they are also involved in eye specification (Table 2.1).
Experiments both in vivo and in vitro indicate that these genes do not function as a 
linear biochemical or enzymatic pathway but, upon interacting with each other bulding 
up a complicated interwoven regulatory network (Figure 2.3) (Hunt, 1970; Chen et al., 
1997; Halder et al., 1998a; Hazelett et al., 1998; Czerny et al., 1999; Niimi et al., 1999;
Bui et al., 2000b; Seimiya and Gehring, 2000). In Drosophila, removal of any of these 
seven ‘core’ eye-specification genes in the eye primordium results in a drastic
reduction or deletion of the adult compound eye, whereas ectopic expression of these 
genes (except so) results in the induction of retinal development outside the normal eye
tissue (Halder et al., 1995; Bonini et al., 1997; Shen and Mardon, 1997; Czerny et al.,
1999; Seimiya and Gehring, 2000). In humans, several retinal disorders have been 
attributed to mutations in the human homologues of these fly eye-specification genes; 
for example, aniridia and bilateral anopthalmia are due to mutations in the human
homologues of ey and so, respectively (Table 2.1) (Jordan et al., 1992; Hanson et al., 
1993; Gallardo et al., 1999). 
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Figure 2.3 Eye specification in Drosophila
Several nuclear factors, patterning molecules
and signaling cascades orchestrate in an 
intriguing interplay the specification and
development of the eye.
The arrows show the direction of the 
relationship. Blue arrow means activator 
whereas red arrow indicate inhibition.
Dac, Dachshund; Dpp, Decapentaplegic; Egfr,
Epidermal growth factor receptor; Exd, 
Extradenticle; Ey, Eyeless; Eya, Eyes absent;
Eyg, Eye gone; Hh, Hedgehog; Hth,
Homothorax; MAPK, Mitogenactivated protein
kinase; RTK, receptor tyrosine kinase; So, Sine 
oculis; Toy, Twin of eyeless; Tsh, Teashirt.
From (Kumar, 2001) modified after (C. Punzo,
pers. comm.)
Besides the molecular mechanisms that specify the tissue to adopt an eye fate, different
genes and their function in patterning the retina are conserved between insects and 
mammals.
In Drosophila the first cells to become committed to a neuronal fate are the R8 
photoreceptor cells. Each R8 recruits surrounding undifferentiated cells to form an
ommatidium and is therefore called ‘the ommatidium founding cell’. To adopt their 
fate, R8 cells need the expression of the basic helix-loop-helix transcription factor 
atonal (Jarman et al., 1994). Atonal expression is detectable as a stripe on the imaginal
disc that coincides with the morphogenetic furrow and signifies R8 competence in 
front of this wave of differentiation. By lateral inhibition, where again Notch-Delta 
signaling is involved, the expression of atonal gets refined to an evenly spaced grid of 
cells that become R8 (Figure 2.4). 
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Table 2.1 Factors involved in vertebrate and Drosophila eye development
Fly genes Protein Vertebrate gene(s) Loss-of-function
phenotype
Expression pattern
twin of eyeless (toy)
and eyeless (ey)
Homeodomain/
paired domain
Small eye (Pax6) Aniridia Anterior neural plate,
optic vesicle, lens placode
and cornea 
sine oculis (so) and
optix
Homeodomain/
Six domain
Six family (Six3, Six6) Bilateral
anophthalmia
Anterior neural plate,
optic vesicle and stalk, 
neural retina and lens
eyes absent (eya)
(clift (cli))
Novel,
Proteinphosphatase
Eya1–Eya4 BOR syndrome Eya1 in lens placode;
Eya3 in vesicle, lens
vesicle and retina
dachshund (dac) Novel Dachshund homologue 1/2
(Dach1, Dach2)
Unknown Dach1 in optic vesicle, 
optic cup and retina;
Dach2 in retina and 
surrounding mesenchyme
eye gone (eyg) Homeodomain Unknown, Pax6 splice
variant
Unknown Unknown
hedgehog (hh) Secreted
morphogen
Sonic hedgehog (Shh),
Tiggy winkle hedgehog
(Twhh), Indian hedgehog
(Ihh) and Desert hedgehog
(Dhh)
Cyclopia Shh and Twhh in neural
retina and retinal 
pigmented epithelium
atonal (ato) bHLH transcription
factor
Mouse atonal homologue 5 
(Math5)
Loss of RGC Optic cup, RGC precursor
EGF receptor (Egfr) Receptor
tyrosine kinase
Waved2 Anterior segment
dysgenesis, loss of 
anterior chamber,
corneal scarring
Perioptic mesenchyme,
eyelid epithelium, corneal 
epithelium
Notch (N) Transmembrane
receptor
Notch1–Notch4
(N1–N4)
Retrolentricular
hyperplasia,
bilateral
microphthalmia
N1 in neural retina; N2 in
lens and  retinal
pigmented epithelium; N3
in lens and neural retina
decapentaplegic
(dpp)
TGF-?-secreted
morphogen
BMP family
(BMP4, BMP7)
Block in lens
induction, bilateral
anophthalmia
BMP4 in optic vesicle,
lens placode; BMP7 in
surface ectoderm, lens 
placode, optic vesicle and
stalk
Crumbs (crb) Transmembrane
protein
CRB1 Retinitis
pigmentosa
(human)
Retina
Sparkling (spa) homeodomain Pax2 Optic nerve
coloboma (mouse,
human)
Optic stalk
Orthodentical (otd) homeodomain Crx Cone-rod
dystrophie, Leber
congenital
amaurosis (mouse)
Neural retina 
bHLH, basic helix–loop–helix; BMP, bone morphogenetic protein; BOR, branchiootorenal dysplasia; EGF, epidermal
growth factor; Pax, paired box; RGC, retinal ganglion cell; Six, sine oculis homeobox; TGF-?, transforming growth factor-
?. From (Kumar, 2001) and (Wawersik and Maas, 2000) modified after (Seimiya and Gehring, 2000)
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In eyes of different vertebrates, close homologues of atonal have been identified that 
are involved in neurogenesis: Xath5 in Xenopus, Math5 in Mice (Kanekar et al., 1997;
Brown et al., 1998). Math5 knockout mice lack almost all retinal ganglion cells, 
suggesting that Math5 is the proneural gene for this class of neurons. The significance
of this is that the ganglion cells are the first neurons to differentiate in vertebrate eyes. 
Thus, in mice as in Drosophila, the differentiation of the first retinal neurons require
an atonal homologue. Furthermore, like in the fly, neurogenesis in the vertebrate retina 
has been found to occur in a wave like manner with its starting point near the optic 
stalk (Figure 2.4) (McCabe et al., 1999; Masai et al., 2000).
Besides the transcription factor atonal the promotion of the Drosophila morphogenetic 
furrow requires the signaling molecule Hedgehog (HH) (Heberlein and Moses, 1995).
The first neurons induced close to the optic stalk secrete Hedgehog protein, which 
diffuses anteriorly to promote atonal expression and neurogenesis in immediately
adjacent undifferentiated epithelium. These new neurons then also synthesize
hedgehog and promote furrow progression.
The vertebrate Hedgehog homologous gene, sonic hedgehog (Shh), is also a short-
range signaling molecule. Shh expression in Zebrafish spreads in a wave like manner
over the retina similar to the morphogenetic furrow in the fly (Figure 2.4) (Neumann
and Nuesslein-Volhard, 2000). 
In both, Drosophila and Zebrafish, ectopic Hedgehog leads to the initiation of an 
ectopic wave of differentiation, whereas lack of hedgehog signaling prevents the 
progression of the furrow respectively the wave.
In summary, findings of the last decade indicate that the selector genes like Pax-6
which are involved in specifying tissue to adopt an eye fate and the mechanisms of 
early retinal patterning are conserved from Drosophila to humans despite the different 
appearance of the two eye types. Therefore, the fly seems suitable as a model system to 
study the molecular mechanisms of eye development that lead to a human eye disease. 
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Figure 2.4 ‚The mexican
wave of differentiation’
In Drosophila and Zebrafish
(vertebrate) the first neurons
of the retina that differentiate
require the basic helix-loop-
helix protein atonal/ath5.
In both animals the short
range signaling protein
hedgehog appears to drive the
wave of neurogenesis.
A, anterior; P, posterior; N, 
nasal; T, temporal; OS, optic
stalk
From (Jarman, 2000)
2.2.7. Why using Drosophila as a model system to study a human 
eye disease
Working with Drosophila has the advantage of the very powerful tools that allow the 
discovery of the basic molecular and cell-biological mechanisms that underlie 
biological processes in a complex organism. As an example, ectopic expression of a 
gene - from the start by cloning the cDNA until the homozygous transgenic fly - can 
easily be done in less than four months.
In addition several genetic studies revealed that the basic cell-biological pathways are
remarkably conserved between invertebrates and vertebrates.
The recently completed genome sequence of the fly (Adams et al., 2000) and the 
human genome (Lander et al., 2001; Venter et al., 2001) indicated a high degree of 
interrelatedness between the two species. With the complete sequences of Drosophila
and Human in hand, it was possible to show that out of 287 well defined inherited 
human diseases 178 (62%) have a homologous gene in Drosophila (Fortini et al., 
2000).
In this chapter some examples are given to show how the fly is useful to study the
molecular pathways that lead to human neurodegenerative diseases.
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Parkinson’s disease is a movement disorder of late adult onset. The clinical main
features are resting tremor, rigidity and bradykinesia. In the brains of patients that were 
affected with this disease specific changes like degeneration of dopamine neurons in 
the substantia nigra and the presence of cytoplasmic neuronal inclusions known as
Lewy bodies are found. Most cases are sporadic, but there are also families with 
autosomal dominant Parkinson’s disease where missense mutations (A53T and A30P)
in the Alpha-synuclein gene have been identified (Polymeropoulos et al., 1997; Kruger
et al., 1998). 
To produce the fly model the wild type and the mutated forms of the human alpha
synuclein were overexpressed in Drosophila (Feany and Bender, 2000). The 
transformed flies showed several of the neuropathological features that are specific for
parkinson: They had an age related loss of dopamine neurons, they developed alpha-
synuclein-immunoreactive cytoplasmatic aggregates with a fibrillar appearance like 
the Lewy bodies and the flies showed age related motoric deficits.
Alzheimer's disease is the most frequent reason for dementia worldwide. The 
disease is defined pathologically by extracellular amyloid plaques and intracellular
neurofibrillary tangles, accompanied by neuronal loss.
Amyloid is produced by the action of ??secretase (encoded by presenilin) on the 
amyloid precursor protein (APP). 
Improper cleavage of APP causes the production of the strong amylogenic a?42. The
accumulation of a?42 is increased by mutations either in presenilin or in APP. 
Mutations in these genes are found in familial early onset forms of Alzheimer’s
disease.
Neurofibrillary tangles are composed of aggregated, hyperphosphorylated forms of the
microtubule-associated protein TAU. Mutations in the TAU gene are involved in 
neurodegenerative diseases that are related to Alzheimer’s disease (Hutton et al., 
1998).
In Drosophila, human APP is cleaved by the fly presenilin at exactly the same aa 
position like in vertebrates (Ramabhadran et al., 1993; Fossgreen et al., 1998). 
With mutated forms of APP, presenilin and TAU, fly models were created that showed
similarities to the human disease (Fossgreen et al., 1998; Wittmann et al., 2001). 
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From studies with Drosophila it was recently reported that APP might function as a
receptor and that overexpression of APP causes axonal transport defects
(Gunawardena and Goldstein, 2001).
Studies of presenilin in C. elegans and Drosophila have revealed its function in the
proteolysis of the Notch receptor (Levitan and Greenwald, 1995; Struhl and
Greenwald, 1999; Ye et al., 1999). The importance of this receptor raises the question
whether ??secretase inhibitors are the appropriate means to prevent progression of 
Alzheimer’s disease. 
Huntington's disease is an autosomal-dominant disorder. Patients present with 
chorea, dementia and neuropsychiatric symptoms. All patients have an expansion of 
greater than 35 repeats in the polyglutamine segment of the mutant huntingtin protein 
(Gusella, 1993). The neuropathology is characterized by progressive neuronal loss 
from the striatum and frontal cortex, in association with the presence of neuronal 
intranuclear inclusions (DiFiglia et al., 1997). Expression of expanded (120 
glutamines), but not unexpanded, huntingtin protein under an eye-specific promoter in 
the Drosophila retina produces age-related progressive neurodegeneration 
accompanied by nuclear inclusions (Jackson et al., 1998). The human disease and the 
fly model are related to each other by the degenerative nature of the pathology, the
presence of characteristic intranuclear inclusions and the correlation between the 
number of the polyglutamine repeats and the severity of the disease. 
In vitro, the expanded huntingtin peptide interacts with a histon acetyltransferase and
impairs its activity. By feeding flies with histon deacetylase (HDAC) inhibitors the 
insufficient acetylation of histons in flies that express the mutant huntingin peptide is 
prevented and the flies show a less severe neurodegenerative phenotype (Steffan et al.,
2001).
The above mentioned fly models for neurodegenerative diseases are ideal entry points 
to dissect the molecular mechanisms underlying those complex diseases and to find 
new targets for drug development. Therefore, we would like to produce a fly model for
the early onset of AMD. 
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2.2.8. Model for Malattia Leventinese 
The retina of the adult mammalian eye still contains retinal stem cells, localized to the 
pigmented ciliary margin (Tropepe et al., 2000). Pax-6 and Notch-1 are expressed in 
the retina of aged humans and mice (F. Hafezi, personal communications). The 
function of Pax-6 and Notch-1 in the adult eye is not explored so far but, from the
knowledge of the function of the Notch receptor and the transcription factor Pax-6 in
eye development and the involvement of Pax-6 during regeneration and maintenance
of the eyes in lower invertebrates, we assume that they are also important for
maintenance and regeneration in the adult vertebrate eye.
Furthermore we believe that Malattia Leventinese is not only caused by the 
accumulation  of EFEMP1 underneath the retinal pigment epithelium but also by a loss
of function caused by the point mutation in EFEMP1Arg345Trp. We hypothesize that 
EFEMP1 acts on the retina of adult individuals by modulating the Notch receptor. Its 
convincing similarity to known Notch ligands makes it conceivable that EFEMP1 is a 
direct activator of the Notch receptor.
As a modulator of Notch, a loss of function due to the mutation in EFEMP1 that
causes Malattia Leventinese or an age related downregulation of EFEMP1 like in 
AMD would lead to an reduced activation of the Notch receptor and therefore to an 
insufficient expression of Pax-6. A reduction of Pax-6 in the retina of adult individuals
could have the following consequences:
Retinal progenitor cells (RPC) lose their full retinogenic potential. The replacement of 
lost retinal cells would be impaired.
Differentiated retinal cells might ‘forget’ their identity and undergo apoptosis.
The consequences of this hypothesis would be, that EFEMP1, or any soluble Notch 
ligand, could be a therapeutic means to prevent progression of retinal degeneration of 
aged individuals.
In this thesis we tested whether EFEMP1 is a Notch ligand and if we can use the fly to 
study the function of EFEMP1 and its putative fly homologs in the development and 
the maintenance of the retina of Drosophila melanogaster.
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2.3. Materials and Methods 
2.3.1. Fly work 
All stocks were maintained as homozygous viable or as balanced strains and kept at
18°C in tubes with standard cornmeal medium supplemented with a drop of live yeast.
Monthly the flies have been transferred into fresh tubes. Amplification of the flies for
experimental use was performed in tubes or bottles at 25°C. 
General fly stocks 
Stock      Source 
dpp blink -Gal4 (Staehling-Hampton and Hoffmann, 1994) 
so10-Gal4 (Niimi et al, 1999) 
ey-Gal4     (Halder et al., 1998) 
UAS-Nact     (Shoichiro Kurata 1999)
UAS-Ndn     (Shoichiro Kurata 1999)
UAS-HN-1     (Spyros Artavanis-Tsakonas)
UAS-Notch     (Spyros Artavanis-Tsakonas)
UAS-GFP  (K. Basler)
ELAV-Gal4     (Lin and Goodman 1994)
GMR-Gal4     (M. Freeman)
Rh1-Gal4     (B. Mollerau)
dpp blink -Gal4, UAS-Gal4   (D. Felix)
yw67c23     (U. Kloter)
yw ac (Bruno Bello) 
w; Sp/CyO; rf10/TM6b Hu (Urs Kloter) 
yw 67c23; SM1 Cy / Gla (Urs Kloter) 
yw 67c23; TM3  (Sb, Ser) / ? (Urs Kloter)
Gbe Su(H)4 LacZ    (Jennings et al 1994)
Genotypes generated 
Crosses to generate new genotypes were done according standard procedures. A 
detailed explanation on fly genetics can be found in “FLY Pushing” (Greenspan, 
1997).
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Stock
yw; UAS-EFEMP1; UAS-Notch
yw; UAS-EFEMP1; GMR-Gal4
yw; UAS-EFEMP1; ey-Gal4 
yw; UAS-EFEMP1; UAS-HN-1
yw; UAS-EFEMP1; UAS-chimera
(chimera = extracellular Human Notch-1, intracellular Drosophila Notch as described below)
Transformants
We generated a minimum of two to ten transgenic lines. For lines that showed no 
mutant phenotype a minimum of 5 independent lines were tested. All transgenic lines
were generated in a yw67c23 background using pUAST (Brand and Perrimon, 1993) as 
vector.
Stock
yw67c23; UAS-EFEMP1 
yw67c23; UAS-EFEMP2 
yw67c23; UAS-EFEMP1Arg345Trp
yw67c23; UAS-EFEMP1-sp (-sp = without signal peptide) 
yw67c23; UAS-chimera
Injections were done according to standard procedures: Collection of embryos on 
grape juice plates for 45 minutes; dechorionation with 4% chlorox; rinsing with 
washing solution and tap water; mounting on grape juice plates and transfer on double
stick tape; drying with hair drier using cold air for about 4 minutes; covering them
with Voltalef 10S oil; injected embryos were kept in a humid box at 18°C until 
hatching.
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Material
Injection buffer 10X: 1mM sodium phosphate buffer; 50mM KCl
Injection solution, DNA: 200ng/µl Plasmid and 150ng/µl helper (pp25.7 D 2-3 wc) 
Washing solution: 0.7% NaCl; 0.03% Triton X-100 
Voltalef 10S oil: Distributed by Elf Atochem (Switzerland)
Grape juice plate: Autoclave solution A (500ml water; 27gr agar) and solution B 
(250ml water; 250ml grape-juice; 12.5gr sugar; 2gr. Nipagin) mix and poor in 
petridishes.
2.3.2. Constructs 
For cloning standard protocols described in (Sambrook and Russel, 2001) were used. 
The additional kits used for DNA purification were obtained from Sigma or
Nucleobond. Constructs were verified by sequencing with 310 ABI sequencer. 
List of cDNAs 
EFEMP1 a commercially available clone covering the whole cDNA of EFEMP1
was ordered from the I.M.A.G.E consortium (clone #380914)
EFEMP2   was cloned as described below 
HN-1 (Human Notch-1) kindly provided by Spyros Artavanis-Tsakonas cloned in 
pcDNA3 (EcoRI - XhoI)
Drosophila Notch kindly provided by Spyros Artavanis-Tsakonas
Inserted into pUAST vector in a 3 way ligation: EcoRI-Asp718(5’), Asp718-XbaI(3’),
EcoRI-XbaI (vector)
EFEMP1 - sp (EFEMP1 without signal peptide) was cloned as described below 
Chimeric Notch was cloned as described below 
cDNA of EFEMP2 
EFEMP2 was cloned using a human Liver cDNA library (kindly provided by Michael
Podvimec).
Primers were designed as follows: two primers next to each other were created from
upstream of the translation start of EFEMP2 (EFEMP2 5’1, EFEMP2 5’3); another 
two primers were created at the 3’ end  also only a few base pairs away from each
other (EFEMP2 3’1, EFEMP2 3’2). 
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A first PCR amplification step was done with the outer pair of primers (30 cycles with 
Adv 2 HF (Advantage-2 High Fidelity PCR kit from CLONTECH (Cat# K1914-1))) 
which led to an unspecific amplification of several DNA pieces. A second 
amplification step with the inner primer pair from the product of the first amplification
resulted in the expected 2kb DNA piece, which was confirmed to be EFEMP2 by
sequencing.
EFEMP2 was subcloned with TOPO TA Cloning® Kit from Invitrogen and cloned into 
the pUAST vector for fly transformation (NotI-Asp718).
Primers
EFEMP2 5’1    5-3 5’ CAAGCTTGGCACGAGGGCAGGCATTGCCCG 3’
EFEMP2 5’3    5-3 5’ GCCAGCCGAGCCGCCAGAGCCGCG 3’
EFEMP2 3’  3-5 5’ CCAGTTGCCTCGTTTTATAGAAAAACAGGCCCAGG 3’ 
EFEMP2 3’2  3-5 5’ GGAATGGAACCCAGGGCCTCCTGGCGC 3’ 
EFEMP1 without signal peptide (EFEMP1-sp) 
The sequence from the EagI site upstream of the translation start as far as the BsaAI
site in the sequence of EFEMP1 was deleted and replaced by a designed linker DNA 
that replaces the deleted sequence except for the signal peptide. Thus, all the sequence
upstream of the start codon remained unchanged making it likely, that this construct is
expressed similar to the wildtype EFEMP1 construct used before. 
Amino acid sequence that is deleted in this construct 
LKALFLTMLTLALVK
Oligos to create the linker DNA ( EagI-BsaAI ) 
EF1woSP 5’3’
5’GGCCGACAGATTCACAATGTCACAGGACACCGAAGAAACCATCAC3’
EF1woSP 3’5’
5’GTGATGGTTTCTTCGGTGTCCTGTGACATTGTGAATCTGTC3’
Construction of Chimeric Notch 
A linker DNA piece was created by PCR using Drosophila Notch as a template and
the chim 5’ and chim 3’ primers with the Adv 2 HF. This linker was sub cloned with 
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the TOPO TA Cloning® Kit from Invitrogen. The linker DNA was cleaved with AatII
and XmnI.
Human Notch-1 (Human Notch-1 (EcoRI - XhoI) in pBluescript II KS (from
Stratagene)) was cleaved with EcoRI and XmnI, producing a 4.5kB DNA fragment
corresponding to the ‘extracellular’ part of Human Notch-1. 
Drosophila Notch (Drosophila Notch (EcoRI - XbaI) in pBluescript II KS) was 
cleaved with AatII and XbaI, producing a 3.2kB DNA fragment corresponding to the
‘transmembrane and intracellular’ part of Drosophila Notch. 
All three pieces were ligated at the same time into the pUAST vector (EcoRI - XbaI).
Chimeric Notch is a protein that comprises the extracellular part from Human Notch-1 
and the transmembrane and intracellular part from Drosophila Notch. 
Primers
Chim 5’   5-3 5’ CGGCCAACGAGTGCTGGAAGTACTTCAAGAACGGC
Chim 3’   3-5 5’ CGTCGACGTCGCGACATAACCGCCGC
GAAGTACTTC XmnI recognition site; GACGTC AatII recognition site 
Directed mutagenesis of EFEMP1 
Two primers were designed (MutEFEMP1 5’, MutEFEMP1 3’), one in 5’-3’ and the 
other in 3’-5’ direction, covering the region of EFEMP1 which harbours the mutation
responsible for Malattia Leventinese. The primers included one base pair mismatch so 
that the copies produced by PCR of EFEMP1 coded the mutated form EFEMPArg345Trp.
As template the whole plasmid  (EFEMP1 in KS II) was used in a 10 cycle PCR 
reaction with Adv 2 HF.
To destroy the template after the PCR reaction I made use of the fact that PCR 
amplified DNA is not methylated, whereas DNA amplified from bacteria is. Thus, by 
cleaving the product from the PCR reaction with DpnI, which only cleaves methylated
DNA, the wildtype template gets destroyed. 
After the cleavage step the PCR product was directly used to transform E. coli. 
To control whether the mutagenesis had worked, DNA from different clones was 
cleaved by NciI, which only cleaves DNA that has the mutation in it. 
The mutagenised plasmid EFEMP1 was named EFEMP1Arg345Trp
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PCR-Primers for directed mutagenesis of EFEMP1: 
MutEFEMP1 5’             5’ GAATGCTGGGAGGATGAAATGTGTTGG 3’ 
MutEFEMP1 3’   3’ CTGGTGTTTACTTACGACCCTCCTAC 5’ 
Constructs used in the pull-down assay
The fragments of EFEMP1 that were used for the pull-down assay were cloned by 
PCR (Adv 2 HF). The primers were created with an EcoRI cleavage site at their 5’ end 
and a XhoI site at their 3’ end. The PCR fragments were cloned into the pGEX Vector
(Pharmacia):
For the fragments the following primer pairs were used: 
DSL TranslStrt 5’, DSL Domain 3’ 
EFEMP1-DSL EGFstart  5’, EFEMP1 3’
DSL+2EGF TranslStrt 5’, DSL2EGF 3’
EFEMP1 TranslStrt 5’,  EFEMP1 3’ 
Primers
EGFstart  5’         5-3 5’ CCACCGAATTCAGTGTGCAGCAGGCTAC
TranslStrt 5’         5-3 5’ GCTAAGAATTCCAATGTTGAAAGCCC
EFEMP1 3’          3-5 5’ GCTCGAGCTAAAATGAAAATGGCCCCAC
DSL Domain 3’    3-5 5’ GCCTCGAGCTGGATACGGTGGGAAGGG
DSL2EGF 3’        3-5 5’ CTCTCGAGGCAATAAAAAGTCCGGGTTG
CTCGAG XhoI recognition site; GAATTC EcoRI recognition site
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2.3.3. Molecular methods 
Standard molecular methods like miniprep, DNA digestion, alkaline phosphatase 
treatment, phenol-chloroform extraction of DNA, ligation, preparation and 
transformation of competent cells, western blotting were performed according to 
(Sambrook and Russel, 2001) and will not be further described. Only additional
information about some protocols less commonly used are given in this section. 
Western blotting 
Polyacrylamid gels (usually 10%) were run at 150V and transferred overnight at 50mA
onto a nitrocellulose membrane. Transfer was verified by Ponceau red staining. The
samples were boiled for 6 minutes in Laemmli buffer.
Concentration of primary antibodies used: ?
Mouse monoclonal EFEMP1 (Marmorstein et al., 2002) 1:2000
The secondary antibody for detection of the signal was used at a dilution of 1:2000 
(HRP-coupled mouse antibody from DAKO A/S) and the signal was detected using a
chemoluminescence kit (Amersham).
Pull-down Assay
Pull-down assays are used to detect protein-protein interactions. One of the putative
binding proteins is synthesized as a GST-fusion protein. Such a fusion protein can 
easily be purified due to the high affinity of GST to glutathione Sepharose. A putative 
binding protein is radiolabelled and tested whether it co-purifies with the GST-fusion
protein.
Protein synthesis in E.coli and affinity purification of the fusion protein was done 
according the GST gene fusion system manual from Pharmacia.
10 ?l (1?g) from E.coli synthetisized GST-EFEMP1 (for constructs see above) fusion 
proteins were incubated together with 1-5?l in vitro translated (TNT Coupled
Transcription/Translation System, Promega), S35 marked extracellular part of Human
Notch-1 for one hour at RT. 
????l glutathione Sepharose 4B (Pharmacia) beads were pre-blocked with 50 ?g
Bovine serum albumin (BSA) for 15 min at room temperature (RT) followed by 
washing twice with 1ml phosphate-buffered saline (PBS) +0.01% NP40. 500 ?l PBS + 
0.01% NP40 (Nonidet P-40) were added. 
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The incubation mixture was added to the pre blocked beads. The mixture was
incubated on a rotating wheel at RT for 45 min to 60 min.
The beads that bound the GST fusion protein (EFEMP1, DSL, EFEMP1-DSL,
DSL+2EGF) and eventually  the Human Notch-1 extracellular part were washed 3 
times with 1ml IPP150 (10mM Tris-Cl pH 8.0, 150mM NaCl, 0.1%NP40). 
The washed beads suspended in 24 ?l protein loading buffer (Laemmli buffer) were
boiled for 5 minutes and loaded into a 10% SDS gel. 
To detect a ‘pull down’ of S35 marked HN-1 extracellular part the SDS gel was 
exposed overnight to an X-ray film (BioMax MS-1 Film, Kodak). 
Production of EGF10-13 from Drosophila Notch 
EGF repeats are intramolecular linked by 3 disulfide bridges which only form in 
oxidizing environment. In vivo, the establishment of such bonds is assisted by 
disulfide-isomerases.
Drosophila Notch EGF10-13 comprises 4 EGF repeats and therefore 12 disulfide
bridges. To make sure that these repeats are folded properly we made use of a signal 
peptide that directs EGF10-13 to the periplasmatic space. Furthermore we co-
expressed a disulfide-isomerase to the periplasmatic space and added N-Acetylcysteine
as a Redox buffer to the LB medium.
EGF10-13_His@Cterm:
The EGF10-13 repeats of Drosophila Notch were amplified by PCR. The primers were
designed in a way that the PCR product had a StuI site at the 5’ and a 6xHis tag
followed by a HindIII site at the 3’ end. This PCR product was cloned StuI-HindIII
into pRBI-DsbC (Maskos et al., 2003) resulting in pEGF10-13, 6xHis@C’-DsbC. That 
way, EGF10-13 are cloned downstream of a signal peptide (OmpA) that directs the
protein to the periplasmatic space. Furthermore EGF10-13 is cloned within a 
polycystronic unit that co-expresses a disulfide isomerase to the periplasmatic space.
Protien charakteristics: pI 4.64, MW 18kD 
Purification of recombinant EGF10-13 with 6xHis at its carboxyterminus:
E. Coli JM83 cells carrying the plasmid pEGF10-13, 6xHis@C’-DsbC were grown in 
LB medium containing ampicillin (100 ?g/mL) at 37°C, over night (ON). 3L LB 
medium containing ampicillin (100 ?g/mL)  was infected with 60ml from the ON 
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culture and incubated at 26°C to an OD600 of 1.0 (4-5 hours incubation). IPTG and N-
Acetylcysteine were added to final concentrations of 1mM and 5mM, respectively 
(0.82 g/L of solid N-acetylcysteine was added) and the culture was incubated for
another 16 hours at 26°C.
The culture was cooled down on ice and centrifuged at 7K (SLA-3000) for 10 min.
The cells were resuspended in 300ml 20%sucrose, 30mM Tris-HCl pH 7.9. EDTA was
added to 1mM final conc. and the cells were incubated 5-10 minutes at room 
temperature (not longer!). 
The cells were centrifuged (7K for 10 min in SLA-3000) and the supernatant was
removed. The cells were resuspended in ice-cold 5mM MgSO4 and incubated for 10 
min at 4°C on a magnetic stirrer. 
The cells were centrifuged (7K for 10 min SLA-3000) and the cold osmotic shock 
fluid was collected in the supernatant.
To adjust the cold osmotic shock fluid for the Ni-NTA purification, the following
chemicals were added: Imidazole to 5mM, NaCl to 500mM, Tris-HCl pH 7.9 to 20 
mM, NP-40 to 0.1%, CaCl2 to 2mM.
500 ?l Ni-NTA superflow (Qiagen) was equilibrated with binding buffer. The 300ml
cold osmotic shock fluid was loaded on the Ni-NTA with 100ml per hour. The Ni-
NTA was washed twice with 10ml wash buffer. 6 elution fractions of 1.5ml were 
collected and analysed on a 15%SDS page. 
The fractions containing protein were pooled and dialyzed against storage buffer. 
To confirm that the produced protein is EGF10-13 a MALDI (Matrix-assisted Laser 
Desorption/Ionization) was performed.
Yield: 50-100?g for 3l 
In a 25l fermenter preparation the yield was also only around 100?g for the entire 25l 
culture!
Binding buffer    Wash buffer
5mM  Imidazole   40mM  Imidazole
500mM NaCl    500mM NaCl
20mM Tris HCl pH 7.9 20mM Tris HCl pH 7.9 
2mM CaCl2 0.1% NP-40
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Elute buffer     Storage buffer
1M  Imidazole   100mM NaCl
500mM NaCl    50mM  Tris HCl pH 7.9
20mM Tris HCl pH 7.9 0.01% NP-40
0.1%  NP-40    10% Glycerol
2mM CaCl2 2mM CaCl2
Protease inhibitors: For 300 ml, 100?l Leupeptin (2mg/ml in H20), 175?l pepstatin 
(2mg/ml in Ethanol) and 2,5ml PMSF (0,1M in Ethanol) was added. 
2.3.4. Histology 
The histological methods used are standard procedures and therefore won’t be further 
discussed, except for the references given. In situ hybridization on discs was
performed as described in protocol 82 (Ashburner, 1989). Antibody staining of discs
was performed according to (Halder et al., 1998a).
The dilution of the antibodies was as follows:
Monoclonal mouse anti-EFEMP1 (Marmorstein et al., 2002) 1:2000
Secondary fluorescent antibodies were diluted 1:500.
Secondary HRP-coupled antibodies were diluted 1:500 and detected by DAB 
(diamino-benzidin).
2.3.5. Cell Culture Methods 
Baculovirus system 
Protein was synthesized according to the BAC-TO-BAC Baculovirus Expression
System Manual from GibcoBRL. 
500ml SF900 medium with 0.5 x106 SF9 cells were infected with the baculovirus and
incubated for 4 days. The 6xHis tagged EFEMP1 protein was purified with Ni-NTA 
(Qiagen) according to the pET System Manual from Novagen.
Maintenance of COS cells 
COS cells were split 1:10 every 3-4 days.
The cells are grown in DMEM media.  The recipe is as follows:
For 500 ml
440 ml DMEM w/o L-glutamine
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50 ml Fetal Bovine Serum, 30 min heat inactivated at 65°C
5 ml 200 mM stock solution of L-Glutamine (Gibco-BRL # 25030-081) 
5 ml 100X stock of Penicillin-Streptomycin (Gibco-BRL #15070-063) 
Notch activity assay 
We used a cell culture assay to detect Notch activity (kindly provided by S. Artavanis-
Tsakonas). The core element of this in vitro assay is a plasmid which contains six 
Su(H) binding sites in front of a minimal promotor that drives the expression of a 
luciferase gene. Upon binding of a ligand, the Notch receptor gets cleaved, NIC enters 
the nucleus and binds to Su(H). This interaction converts Su(H) from a repressor into a
transcriptional activator and drives the expression of the luciferase gene. The luciferase 
acts on its substrate and leads to a measurable light formation.
The night before transfection the cells were plated in a 24-well tissue culture plate at 
5x104 cells per well. For the ligand expressing cells, 25x104 cells were plated in a 6-
well tissue culture plate.
Cells are transfected using Lipofectamine Plus reagent (Gibco # 10964-013).  For each 
well, 0.5 µg of TP1-Luc (Luc = Luciferase) and 0.003 µg of CMV-renLuc are
transfected (the plasmids were kindly provided by S. Artavanis-Tsakonas).  The CMV-
renLuc plasmid is used to normalize the firefly luciferase values coming from the TP1-
Luc plasmid. In addition, 0.5 µg to 1µg of pcDNA3-HN-1 were co-transfected into the
cells. The ligand expressing cells were transfected with 2.5 µg to 5 µg of pcDNA3-
EFEMP1 (pcDNA3 from Invitrogen). 
?  In a polypropylene tube DNA (TP1-Luc + CMV-renLuc + pcDNA3-HN-1), PLUS
reagent, and OPTIMEM (GibcoBRL # 31985-070) were mixed. 0.5 µg TP1-Luc, 0.003 
µg CMV-renLuc, 4 µl of PLUS reagent, and 25 µl of OPTIMEM for each well were 
used.  The well mixed DNA and PLUS reagent were incubated at room temperature for
15 minutes.
?  In a separate tube, 1µl Lipofectamine and 25 µl OPTIMEM were mixed and 
incubated for 15 minutes.
?  During this incubation, the cells were washed one time in 1 ml of OPTIMEM and 
afterwards covered with 200µls of OPTIMEM. 
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?  To the 200 µl of OPTIMEM, 50 µl of the Lipofectamine PLUS/DNA reagent was 
mixed into each well.
?  Cells were incubated in a tissue culture incubator for 3 hours.  After 3 hours, the
transfection reagent was replaced with 1 ml of normal DMEM media.
The day following transfection nothing was done with the cells, giving them a day to 
recover.
The second day following transfection, the transfected cells (pcDNA3-HN-1 and 
reporter constructs) were co-cultured with 1x105 ligand-expressing (pcDNA3-
EFEMP1) cells or with 1x105 Delta expressing cells as positive control. The DMEM
media was simply aspirated from the transfected cells and the ligand-expressing cells 
were added. 
Transfected cells were co-cultured with ligand-expressing cells for 24-30 hours. 
After the co-culture is complete, cells are harvested for measurements of luciferase 
activity. Luciferase activity is measured using the Dual-Luciferase Reporter Assay
System (Promega #E1960).  All reagents and a manual are provided in this kit.
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2.4. Results 
2.4.1. In silico structure comparison between EFEMP1 and known 
Notch ligands 
All Notch ligands known so far are single pass transmembrane proteins containing 
between two (Lag-2, the C. elegans Notch ligand) and 16 EGF repeats in their 
extracellular domain (Lissemore and Starmer, 1999). Furthermore, they share a DSL 
domain adjacent to the EGF repeats. Comparison of the DSL domains from different 
Notch ligands of different phyla revealed a consensus of eleven amino acids 
(Lissemore and Starmer, 1999). The DSL domain is crucial for the physical interaction 
with the EGF repeats number 11 and 12 from the Notch receptor (Rebay et al., 1991;
Shimizu et al., 1999). 
EFEMP1 is a protein of the extracellular matrix that is secreted from the RPE 
(Marmorstein et al., 2002) of the human eye and thus does not have a transmembrane
domain. Like the known Notch ligands it comprises several EGF repeats. EFEMP1 has
5 EGF repeats and an additional atypical EGF domain. (Human Delta1 has 8 EGF
repeats (Swiss-Prot: O00548), Drosophila Delta has 9 EGF repeats (Swiss-Prot:
P10041)).
By comparison of its sequence with the DSL consensus, we found that the atypical 
EGF repeat of EFEMP1 is related to the DSL consensus sequence. In this putative
DSL domain 8 out of the 11 consensus amino acids are present (Figure 4.1) 
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DSL Domain
DSL consensus C - - - Y - - - - C - - - C - - - - - - - - - - - C - - - G - - - C - - G W - G - - C
EFEMP1 C T D G Y E W D P V R Q Q C K D I D E C D I V P D A C K G G M K . C V N H Y G G Y L C
EFEMP2 C T D G Y E W D P D S Q H C R D V N E C L T I P E A C K G E M K . C I N H Y G G Y L C
A
Delta
DSL EGF TM
B
EFEMP1
Figure 4.1 Putative DSL domain of EFEMP1 and comparison of EFEMP1 with Delta
A Close to the aminoterminal end of EFEMP1 a putative DSL domain was found that fits with eight out 
of eleven amino acids to the consensus sequence of DSL domains.
Red amino acids show the DSL consensus (these 11 amino acids and the distance between them are
conserved in almost all Notch ligands described so far (Lissemore and Starmer, 1999)).
Blue boxed amino acids indicate matches between the DSL consensus and the putative DSL domain of 
EFEMP1 and EFEMP2. Dash = any amino acid; point = gap; 
DSL consensus from (Lissemore and Starmer, 1999); EFEMP1 from NCBI accession NP_4096, aa29-
70; EFEMP2 from NCBI accession AAF65188 aa39-80.
B Comparison of EFEMP1 with Delta (a Drosophila Notch ligand) shows that they share a similar
structure. TM = Transmembrane domain.
2.4.2. Overexpression of EFEMP1 / EFEMP1Arg345Trp in Drosophila
Modulation of Notch receptor activity has tremendous effects on the development of
the fly. In eye development for example, expression of a constitutively activated form 
of the Notch receptor (Nact) leads to a strong overproliferation of the compound eye 
(Kurata et al., 2000). Expression of the Drosophila Notch ligands Delta and Serrate
during eye development leads to overgrowth and reduction of the eyes, respectively
(Figure 4.3 C,D). The Drosophila eye is in general a good system to detect slight 
alterations of molecular interactions because morphological abnormalities are easily
observable in the highly repetitive, precisely patterned compound eye; Small changes
in one ommatidium are amplified over the whole lattice of the compound eye. 
Upon expression of EFEMP1 during eye development we would therefore expect a 
deranged compound eye if any signaling is disturbed or even a Notch specific 
alteration of the eye phenotype in the case that EFEMP1 is a Notch ligand.
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As first experiment we tested whether targeted expression (Box 4.1) (Brand and 
Perrimon, 1993) of EFEMP1 in the fly results in any visible change of phenotype. 
Therefore, cDNA of human EFEMP1, EFEMP1Arg345Trp (the mutation that causes ML) 
and EFEMP2 (a human paralog of EFEMP1) was cloned downstream of UAS 
(upstream activation sequences) in a p-element vector and flies were transformed with 
these constructs. These flies were crossed to flies expressing Gal4 under the control of 
different enhancers (Figure 4.2 A). In this way EFEMP1, EFEMP1Arg345Trp and 
EFEMP2 were expressed in the fly during different developmental stages and in 
different tissues. To show that EFEMP1 is expressed at the RNA and protein level,
RNA in situ hybridisation and antibody staining against EFEMP1 was performed on 
imaginal discs of third instar larvae (Figure 4.2 B,C) 
With these overexpression experiments we could not observe any change of the fly
morphology.
GAL 4 protein
F1
expressedGAL 4
 enhancer 
EFEMP1
UAS
X
UAS
EFEMP1
not expressed
Targeted gene expression
Brand and Perrimon, 1993
GAL 4 protein
F0
 enhancer GAL 4
Box 4.1 Targeted gene expression
F0: Two different parental fly strains: 
One fly line has the Gal4 transcription factor from
yeast under control of a genomic enhancer. In these
flies, Gal4 is expressed in the tissue and the
developmental stage specific to the expression
pattern of the enhancer. As a yeast transcription 
factor, Gal4 alone has no effect on these flies.
A second fly line carries a gene of interest (like 
EFEMP1) under the control of the yeast
promotor/enhancer UAS that remains silent in these
flies.
F1: Crossing these lines together results in flies that
express Gal4 in a specific spatial and temporal
pattern which in turn binds to UAS and activates the
transcription of the transgene.
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A eyeless-GAL4
dpp-GAL4
dpp-GAL4, UAS-G
GMR-GAL4
1-Gal4
so-GAL4
Elav-Gal4
Rhodopsin-
UAS-EFEMP1
UAS-EFEMP1 rg345TrpA
UAS-EFEMP2
Xal4
B C
Figure 4.2 Expression of EFEMP1 in the fly
A Flies that drive Gal4 under the control of different enhancers were crossed to flies that are transgenic
for EFEMP1, EFEMP1Arg345Trp and EFEMP2 under the control of UAS.
Enhancers:
dpp expressed in leg, wing, antennae and eye discs
eyeless, so expressed in eye discs (eye specification, early in eye development)
GMR expressed in all cells of the differentiated eye
ELAV expressed in all differentiated neurons, including photoreceptor cells
Rhodopsin-1 expressed in outer photoreceptor cells (R1-R6) (still expressed in the adult) 
B in situ hybridisation with EFEMP1 RNA. Shown is a wing imaginal disc where EFEMP1 is expressed
with the enhancer of the dpp gene along the anterior/posterior compartment boundary.
C antibody staining of the same expression pattern like in B. This pattern is highly specific for the dpp
enhancer and thereby confirms that EFEMP1 is expressed at both, the RNA and protein level.
DCBA
Figure 4.3 wildtype and altered compound eyes
A view onto the normal compound eye of Drosophila
B top view of a the head of a wildtype Drosophila
C expression of Serrate with an eye specific enhancer (ey-Gal4) leads to a reduction of the eye size. 
D expression of Delta with an eye specific enhancer leads to overproliverated compound eyes with an
increased number of ommatidia.
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2.4.3. Expression of EFEMP1 together with human Notch-1 and a
chimeric Notch 
EFEMP1 is a human protein. Thus, even though Drosophila Notch and Human Notch-
1 share almost 60% amino acid identity and have the same protein domains, it could be 
that the lack of phenotypic effects is due to a lack of interaction between the human
EFEMP1 and the Drosophila Notch due to minor differences in their amino acid 
sequences. To test this hypothesis, EFEMP1 was expressed together with the Human 
Notch-1 receptor in Drosophila. Expression of Human Notch-1 alone during eye
development behaves like a dominant negative form of Notch and disrupts eye
development. It is likely that this phenotype is due to a competition of Drosophila
Notch and Human Notch-1 for the ligands where the Human Notch-1 is able to bind 
the ligand but is not processed properly resulting in an inadequate activation of the 
Notch pathway. By expressing EFEMP1 together with Human Notch-1 we expected to 
suppress this phenotype by increasing the level of ligands. However we did not see any 
change of the Human Notch-1 caused phenotype by coexpressing EFEMP1 and Notch-
1 during eye development.
One could still argue that even though EFEMP1 now would interact with the
extracellular part of the human Notch-1, the intracellular part of human Notch-1 does 
not transduce the signal properly to the nucleus of Drosophila cells. Therefore, a 
chimeric Notch was constructed that consists of the extracellular part of human Notch-
1 and the intracellular and transmembrane part of Drosophila Notch (Figure 4.4). But 
still, overexpression of EFEMP1 together with this chimeric Notch did not result in an
EFEMP1 specific phenotype. 
ANKEGF
Human Notch
LNR RAM
Extracellular Intracellular
PEST
Drosophila Notch
Figure 4.4 Chimeric Notch
The extracellular, human part of this chimeric Notch should be able to interact normal with the human
protein EFEMP1, whereas the intracellular part from Drosophila should signal properly to the nucleus.
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2.4.4. Expression of a mammalian protein in Drosophila
Notch and its ligands have several EGF repeats which are intramolecularly linked by
disulfide-bonds which only form extracellular under oxidative conditions.
Furthermore, Notch signaling is dependent on enzymes that modify these EGF repeats 
like the glycosyltransferase fringe (Bruckner et al., 2000) and the O-fucosyltransferase 
OFUT1 (Okajima and Irvine, 2002). Taken together, it seems crucial for Notch and its
ligands that they are secreted, folded and modified properly to get their full activity.
As a first test whether the mammalian EFEMP1 is normally secreted in flies we looked 
at signal peptides of different mammalian and fly proteins and compared them to 
EFEMP1 (Table 4.1). From the literature we know that signal peptides do not have a 
well-defined consensus sequence, but share some features: they range in length from
13 to 36 residues, the aminoterminal part contains at least one positively charged 
residue and they bear a highly hydrophobic stretch, typically 10 to 15 residues long 
(Stryer, 1999). The signal peptide of EFEMP1 fulfills these criteria and there seem no 
distinctions between insect and mammalian signal peptides. In addition, Invitrogen
writes in one of their protocols that all mammalian secretion signals they have tested
functioned properly in insect cells (Invitrogen, 2002). 
EFEMP1 M L K A L F L T M L T L A L V K S
EFEMP2 M L P C A S C L P G S L L L W A L L L L L L G S A
Delta 1 Human M G S R C A L A L A V L S A L L C
Notch1 Human M P P L L A P L L C L A L L P A L A
Delta Drosophila M H W I K C L L T A F I C F T V I V
Drosophila Glue Protein M K L L V V A V I A C M L I G F A
Table 4.1 Signal peptides
Amino-terminal signal sequences of some eukaryotic secretory and plasma membrane proteins. Most of
them share a hydrophobic core (yellow) and a basic residue (blue).
For our in vitro assays that are described below we synthesized EFEMP1 in different
ways. For the pull-down assay we produced EFEMP1 in bacteria and purified the 
protein from the lysed cells. For the cell culture assay we synthesized EFEMP1 with
the baculovirus system from which we purified EFEMP1 from the supernatant of these 
insect cells. Thus we have EFEMP1 produced by bacteria and therefore without
properly formed EGF repeats and EFEMP1 produced by a eukaryotic cell system 
where we expect the EGF repeats to be folded correctly. When we run these two 
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different proteins on either a SDS gel under reducing conditions or on a SDS gel under
non-reducing conditions we see that they behave differently. EFEMP1 from bacteria 
behaves the same in both reducing and non-reducing conditions (Figure 4.5 B lane 2,3 
and 5,6). EFEMP1 from the eukaryotic system migrates different in these two diverse
conditions. In reducing conditions, only one band with the expected molecular weight
is visible on a western blot (Figure 4.5 A lane 1-4 and B lane 1). In non-reducing 
conditions, two bands with an apparently higher molecular weight appear on the 
western blot (Figure 4.5 A lane 5-8 and B lane 4). Although this is not a proof for well
formed EGF repeats it is what one would expect if this domain is properly folded. 
reducing | non-reducing
B 1 2 3 4 5 6
reducing | non-reducing
A 1 2 3 4 5 6 7 8
150kD 150kD
75kD 75kD
50kD 50kD
Figure 4.5 EFEMP1 under reducing or non-reducing conditions, produced from insect cells or bacteria
A Different fractions of EFEMP1 produced with the baculovirus system (insect cell system)
lanes A 1-4 (and B 1) different fractions of EFEMP1 under reducing conditions, where
disulfide bonds are broken; only one band with the expected molecular weight appears.
lanes A 5-8 (and B 4) the same fractions under non-reducing conditions (without ?–
mercaptoethanol in the loading buffer) where disulfide bonds remain stable; additional bands
with apparently higher molecular weight appear probably due to different migration properties
of the stably folded EGF domains.
B   lanes 2,3 and 5,6 EFEMP1 produced in bacteria
lane B1 the same protein like in A1/A5 under reducing conditions.
lane B4 the same protein like in A1/A5 under non-reducing conditions.
lanes B 2, 3 EFEMP1 produced in bacteria under reducing conditions (arrow)
lanes B 5, 6 the same proteins like in lanes B 2, 3 under non-reducing conditions (arrowhead)
(without ?–mercaptoethanol in the loading buffer).
EFEMP1 produced in bacteria migrates similar in reducing and non-reducing conditions,
indicating that in bacteria EGF repeats are not intramolecular linked by disulfide bonds.
The different molecular weight of the protein that was produced in bacteria is due to a GST
domain that was fused to EFEMP1 for purification. In addition, several bands with lower
molecular weight appear in lane 2,3 and 5,6 that are due to degradation of the protein.
Finally we made confocal pictures of imaginal discs where the human EFEMP1 is 
expressed (Figure 4.6). These pictures do not allow us to precisely assign the protein to 
the extracellular matrix but at least the antibody staining is clearly visible in the space
between the nuclei where we would expect a secreted protein. We made similar
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pictures of the expression pattern of EFEMP1Arg345Trp (not shown) but we could not 
observe a different localization of the mutated protein as it was observed in cell
cultures (Marmorstein et al., 2002). These pictures are not sensitive enough to clearly 
distinguish between a localization of the protein in the cytoplasm and the extracellular 
matrix.
Taken together we have no reason to believe that the human EFEMP1 is not processed 
normally when we overexpress it in the fly or with any other insect cell system.
CA B
Figure 4.6 Immuno-localization of EFEMP1 in fly imaginal discs
A-C confocal picture of the same sector of a wing imaginal disc. 
A Antibody staining against EFEMP1. B fusion of the pictures A and C. EFEMP1 is localized between
the nuclei, presumably to the extracellular matrix. C  staining of the nuclei with SYTOX Green.
2.4.5. Notch activity measurement using a cell culture assay 
To further test whether EFEMP1 is able to activate the Notch receptor, a cell culture 
assay was used (kindly provided by S. Artavanis-Tsakonas). The core element of this
in vitro assay is a plasmid which contains six Su(H) binding sites in front of a minimal
promotor that drives the expression of a luciferase gene. Upon binding of a ligand, the 
Notch receptor gets cleaved, NIC enters the nucleus and binds to Su(H). This
interaction converts Su(H) from a repressor into a transcriptional activator and drives 
the expression of the luciferase gene. The luciferase acts on its substrate and leads to a 
measurable light formation (Figure 4.7)
cDNA of EFEMP1 was cloned into the pcDNA3 vector downstream of a constitutively 
active eukaryotic promoter (CMV). This construct was cotransformed with the reporter
plasmid to COS cells and the cells were tested for luciferase upregulation.
47
Results
With this assay, a constitutively activated Notch receptor led to a more than sixty fold 
upregulation of the luciferase activity whereas there was no detectable increase of the 
light emission due to EFEMP1 (Figure 4.8). Therefore, EFEMP1 is not able to activate 
the Human Notch-1 receptor in this assay. (The apparently activation of the reporter in
lane 5 of figure 4.8 is due to a lower transfection efficiency by adding an additional
plasmid to the transfection mixture and not due to an enhanced activation of the
system.)
NIC
6 * Su(H) binding sites 
Su(H) / CSL 
luciferaseluciferase
6 * Su(H) binding sites 
Su(H) / CSL 
Figure 4.7 Luciferase assay
COS cells were  transfected with a reporter plasmid carrying six Su(H) binding sites upstream of a 
minimal promotor in front of a luciferase gene. Without activation of the Notch receptor, Su(H) acts as 
transcriptional repressor. Upon activation of the Notch cascade by a ligand, NIC enters the nucleus, binds
to Su(H) and converts this transcriptional repressor into an activator. As a result, the luciferase gene gets
transcribed, leading to a measurable light formation by acting on the luciferin substrate.
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Figure 4.8 Cell culture assay to detect Notch activity
COS cells that were transfected with the Notch activity reporter plasmid and a plasmid that
constitutively expresses a luciferase gene to normalize the measurements are referred to as the reporter
cells in the text below. After transfection, the cells were incubated 24 hours until luciferase activity was 
measured.
1 Basal activation. The luciferase activity of the reporter cells alone was measured. This result was 
used to normalize the measurements 1-5.
2 Notch activated. The reporter cells were co-transfected with a constitutively active form of Notch
(consisting of only the intracellular part of Notch) leading to a more than 60 fold activation of the
system.
3 Delta. Stably Delta expressing cells were incubated with the reporter cells leading to a 3,5 fold
activation.
4 EFEMP1 expressing cells (pcDNA3 EFEMP1) were incubated with the reporter cells
5 pcDNA3-EFEMP1 was co-transfected to the reporter cells
6 Negative control. The empty pEGFP/N3 vector was co-transfected with the reporter cells
7 pEGFP/N3 EFEMP1 was co-transfected to the reporter cells (normalized with 6)
8 Negative control. pEGFP/N3 (without insert) expressing cells were co-incubated with the reporter
cells
9 pEGFP/N3-EFEMP1 expressing cells were co-incubated with the reporter cells (normalized with 8)
10-13 Protein that was synthesized with the baculovirus system was added to the reporter cells.
10 Negative control 100 ?l elution with CSF protein, a nuclear protein that served as negative control,
was added to the reporter cells. This protein was produced and purified with the same procedure like
EFEMP1 11 0.5?g EFEMP1 protein (100 ?l of the elution) was added to the reporter cells (normalized
with 10).
12 Negative control 50 ?l elution with CSF protein was added to the reporter cells. 
13 0.25?g EFEMP1protein (50 ?l of the elution ) was added to the reporter cells (normalized with 12)
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2.4.6. In vivo assay to detect Notch activity 
To test whether we can detect an activation of the Notch receptor in vivo, we used flies
that express LacZ under control of Su(H) in cells where Notch is activated (kindly 
provided by S. Bray). To enhance the activity of Su(H), three binding sites for the 
Grainyhead transcriptionfactor (Grh) that is ubiquitously active in imaginal discs was 
cloned in front of the two Su(H) binding sites. In cells where Notch is silent, the
activity of the Grainyhead promotor is blocked by the repressing properties of Su(H).
Conversely, if Notch gets activated and NIC enters the nucleus, Su(H) acts together
with Grh and NIC as an activator of transcription leading to a strong LacZ expression 
(Figure 4.9) (Furriols and Bray, 2001). 
In imaginal discs of third instar larvae, activation of the Notch pathway occurs in a
specific pattern although Notch is expressed in all cells of the disc at this stage (Fehon 
et al., 1991). Therefore we expected an alteration of the endogenous Notch activity 
pattern by expressing a Notch ligand at ectopic positions.
Expression of EFEMP1 in these flies did not result in any variation of the Notch
activity pattern (Figure 4.10 B,E). 
Figure 4.9 Reporter constructA Su(H) binding sites Grh binding sites
A schematic view of the construct
that is integrated into the genome
of flies which were used to detect
Notch activation. Binding sites for 
Grh were cloned upstream of 
Su(H) binding sites that are in
front of a minimal promotor which
drives LacZ expression.
B
B On its own, Su(H) acts as a 
transcriptional repressor and
blocks the activity of Grh.
Together with NIC, Su(H) turns
into a transcriptional activator
which is enhanced by the action of
Grh.
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Figure 4.10 Notch activity reporter flies
A wt eye-antennal disc. LacZ expression (blue) reflects the normal Notch activity pattern, which is 
along the dorsal/ventral boundary and posterior to the MF. 
B eye-antennal disc of a fly in which GMR-Gal4 drives UAS-EFEMP1 expression  shows no alteration
of the endogenous Notch activity pattern.
C in situ with EFEMP1-RNA on an eye-antennal disc from the same flies like in B shows EFEMP1
expression all over the eye disc.
D wt wing disc. LacZ expression reflects the normal Notch activity pattern
E wing disc of a fly where EFEMP1 is expressed shows no alteration of the endogenous notch activity
pattern.
F in situ with EFEMP1-RNA on a wing disc from the same flies like in E shows EFEMP1 expression
reflecting the pattern of the driver that was used to express EFEMP1 (dpp-Gal4).
G expression of the Notch ligand Delta in the entire eye disc expands Notch activity all over the eye 
disc.
H Ectopic activation of the Notch pathway with Delta in the entire eye disc leads to over-proliferated
eyes when compared to wt eyes (in I)
J expression of the Notch ligand Serrate disrupts Notch activity at the dorsal ventral boundary leading to 
smaller eyes (in K) when compared to wt eyes (in L)
For all discs: posterior is to the left, dorsal is top
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2.4.7. Expression of a non-secreted version of EFEMP1
In the human eye, EFEMP1 is secreted from the RPE and is located to the extracellular 
matrix surrounding the outer segments of the photoreceptor cells (Marmorstein et al., 
2002). The mutated form, EFEMP1Arg345Trp, is not properly secreted and accumulates
in and underneath the RPE which could be the mechanism that provokes ML 
(Marmorstein et al., 2002).
Cleaving off the signal peptide, which is crucial for secretion of EFEMP1 to the 
extracellular matrix, should lead to a protein that remains intracellular. Assuming that 
such a non-secreted protein mimics the behavior of EFEMP1Arg345Trp but in an 
enhanced way, where all of the protein remains intracellular, a non-secreted version of 
EFEMP1 (EFEMP1-sp) was created. A question that could be addressed with such a 
protein using the fly as a model system is if intracellular accumulation of EFEMP1 
accounts for the retinal degeneration.
To test whether EFEMP1-sp is expressed, RNA in situ hybridization and antibody 
staining were performed. Whereas mRNA of EFEMP1-sp could be detected (Figure
4.11) it was not possible to detect EFEMP1-sp at protein level. EFEMP1-sp protein 
therefore is either immediately degraded, not translated or expressed at such low levels
that it is not detectable by antibody staining. 
Nevertheless, in 15 different transgenic lines that were screened for mutant phenotypes 
caused by expression of EFEMP1-sp with different drivers (eyeless-Gal4, dpp-Gal4), 
not a single abnormal compound eye was observed. 
Figure 4.11 expression of EFEMP1-sp
In situ hybridization against EFEMP1-RNA on a wing disc where
EFEMP1-sp is expressed under the control of the enhancer of the dpp gene
Along t
.
he anterior/posterior boundary a stripe is visible (arrow), reflecting
the expression pattern of EFEMP1-sp with the dpp enhancer.
posterior is to the left, dorsal is top.
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2.4.8. Pull-down assay 
So far we tested whether EFEMP1 can activate the Notch receptor. We then wanted to 
analyze if EFEMP1 can bind in vitro to the extracellular part of the human Notch-1
receptor and therefore used a pull-down assay.
Four different EFEMP1 constructs were cloned. The whole EFEMP1, EFEMP1
without DSL domain (EFEMP1-DSL), the DSL domain with two EGF repeats (DSL +
2EGF) and the DSL domain alone. 
These EFEMP1 constructs were fused downstream of a GST coding sequence and 
produced from E. coli. The extracellular part of Human Notch-1 was expressed from a
reticulocytelysate and marked with S35 methionin (S35 HN-1EC).
With these constructs we were not able to pull-down the extracellular part of Human
Notch-1 (Figure 4.12). 
2/6  EFEMP1 - DSL 
3/8  DSL + 2EGF
4/9  DSL
X
1/5 EFEMP1
Human Notch-1
exrtacellular part 
LNREGF
Figure 4.12 Pull-down experiment
1-4 Supernatant(SN) after incubation
of S35 HN-1EC with different
EFEMP1 constructs and sepharose
beads. The
1 2  3 4 5  6 7 8 9
S35 HN-1EC is still strong detectable
in the SN.
S35 HN-1EC
5-8 pull down: no S35 HN-1EC was co
purified with the EFEMP1 constructs
that are bound to the sepharose beads
due to their fusion with the GST
protein. The different EFEMP1
constructs do not interact with HN-
1EC  in this assay. 
9 “input” of in vitro synthesized S35
HN-1EC.
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2.4.9. EFEMP1 in aging flies
Malattia Leventinese has an onset of about 40 years and to observe the retinal
degeneration an ophthalmoscope is needed. In our experiments we so far searched for 
dominant phenotypes of the ectopically expressed protein during eye development of
Drosophila. In a next experiment we wanted to know whether over-expression of 
EFEMP1 and EFEMP1Arg345Trp shows an age-related phenotype or a mild phenotype
with macroscopically normal looking eyes, but degenerated photoreceptor cells.
To look for degenerated photoreceptor cells (neurons) in adult and aged flies, we used 
an assay that has previously been used to detect photoreceptor degeneration in flies 
that served as model systems for Huntington’s disease (Steffan et al., 2001). 
If over-expression of EFEMP1 and EFEMP1Arg345Trp causes retinal degeneration in 
aging flies, we would expect a similar phenotype that we see in flies with mutations in 
the rhodopsin-1 gene. In these flies, the outer photoreceptor cells, where rhodopsin-1 is
usually expressed, degenerate (Figure 4.13 C).
To express EFEMP1 and EFEMP1Arg345Trp in the fly retina we used enhancers that 
drive expression to the outer photoreceptor cells (Rh1-Gal4) (Figure 4.13 A) or to all 
cells in the retina (GMR-Gal4) of adult flies. The photoreceptor cells were observed by
light microscopy (Franceschini and Kirschfeld, 1971).
In an observation period of more than two months, by a live expectation of around 
three months, we did not observe degeneration of the photoreceptor cells in the eye of
aged Drosophila (due to the fact that all of these transgenic flies looked normal, only 
the wt picture is shown  (Figure 4.13 B)). 
A B C
Figure 4.13 Photoreceptor cells of ageing flies
Visible in A to C is the light-gathering parts of the photoreceptor cells, the rhabdomeres.
A Green fluorescence protein (GFP) was expressed with the promotor from the rhodopsin-1 gene to test
the driver. Rhodopsin-1 is expressed in the six outer photoreceptor cells (R1-R6) that are green in this
picture.
B Representative picture of the observe ability of the photoreceptor cells. The picture shows 9
ommatidia in which the rhabdomeres of 7 normal Photoreceptor cells are visible.
C One week old flies with a mutation in the rhodopsin-1 gene which is specifically expressed in the
photoreceptor cells R1-R6. In these flies, the outer photoreceptor cells (R1-R6) are degenerated.
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2.4.10. Exposure of flies to constant light 
In a next essay we tested whether overexpression of EFEMP1 and EFEMP1Arg345Trp in
a constant light environment leads to retinal degeneration. 
The idea for this experiment came out of recent work that was done with the 
Drosophila crumbs gene. 
Drosophila Crumbs is a single pass transmembrane protein. Mutations in the human
homologue of crumbs, CRB1, are associated with retinitis pigmentosa which is a
disease with a progredient loss of vision (den Hollander et al., 1999). 
Drosophila and human Crumbs are similar in structure and are expressed at 
homologous locations in the human and fly retina (Pellikka et al., 2002). In 
Drosophila, the human crumbs can partially substitute for the Drosophila gene (den 
Hollander et al., 2001). 
From experiments with Drosophila it is known, that flies which have clones of 
photoreceptor cells lacking the extracellular part of Crumbs are sensitive to light 
exposure. These flies get photoreceptor degeneration after one week of exposure to 
constant light (Johnson et al., 2002). 
Since the extracellular part of Crumbs comprises several EGF repeats, Crumbs could 
belong to a functionally similar group like EFEMP1.
Therefore we tested whether overexpression of EFEMP1 or the mutated form of 
EFEMP1 that leads to ML could cause retinal degeneration in aging flies that were
kept in constant light. (The flies were illuminated from both sides with two 8 Watt
neon lights.) 
During an observation period of two months, flies that express EFEMP1 or
EFEMP1Arg345Trp  in this constant light environment did not show any signs of retinal
degeneration.
2.4.11. Drosophila Notch EGF10-13 as template for Aptamers 
The idea that Notch signalling is involved in AMD was reinforced by an article that
showed Notch signalling involvement in muscle regeneration (Conboy et al., 2003). In 
this work, the authors showed that in aged mice, the repair mechanism of harmed
muscle cells is impaired and they attribute this to a decline of delta expression in aged
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animals. This is in good agreement with our working hypothesis that a decline of 
Notch signalling is involved in AMD. 
As EFEMP1 has not been proven to be a Notch agonist, we were interested to find 
another soluble molecule that could be used to activate the Notch receptor. Due to their
smallness end ease of production we considered making aptamers as a reasonable 
approach.
Aptamers are known since 1990. At that time, two articles introduced the procedure of 
making aptamers (Ellington and Szostak, 1990; Tuerk and Gold, 1990). In both papers
similar methods are described how a single stranded RNA (or DNA) molecule that 
specifically binds to a target is selected. The procedure was called SELEX (systematic
evolution of ligands by exponential enrichment) and the single stranded RNA (or
DNA) molecules were called aptamers (aptus = “to fit”). The SELEX procedure is 
depicted in (Fig. 4.14). 
Compared to antibodies, aptamers have several advantages. First, it is an in vitro
process and therefore aptamers can be raised against substances that are toxic for 
animals or that have only weak immunogenic properties. Second, the selection 
conditions can be varied (different buffers or temperatures can be used). Third, there is
little batch to batch variation and finally, they can be chemically crosslinked. For
example: F or NH2 groups can be attached to increase the stability against nucleases or 
biotin or fluorescin can be linked for histochemistry purposes (for review 
see(Jayasena, 1999)). 
For our project to use aptamers as soluble Notch agonists for therapeutic reasons,
aptamers have two important advantages: First, they are small (at most 40 nucleotides,
single strand) and therefore well diffusible. Second, they consist of DNA or RNA and
have less immunogenic potential than antibodies. 
Due to their advantageous properties medical research became interested in aptamers.
One aptamer that is in clinical trials is an aptamer against vascular endothelial growth 
factor (vEGF). Aptamers against vEGF help to prevent choroidal neovascularization,
an undesirable vascular outgrowth secondary to AMD and a leading cause of blindness
(Kim et al., 1993; TheEyetechStudyGroup, 2003).
For the production of the aptamers we collaborate with Larry Gold from Somalogic.
Our part of the collaboration is the production of the protein and the functional assays
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of the aptamers. We would like to test the aptamers we get from Somalogic for their
ability to work as agonist/antagonist on the Notch receptor in cell culture and on 
imaginal discs.
The starting point was the production of the extracellular part of Notch. Notch, as
described previously in this work, has a large extracellular domain including 36 EGF 
repeats. Each EGF domain is intramolecular linked by 3 disulfide bridges in a distinct 
pattern: C1-3, C2-4, C5-6. EGF repeats do not form in a reducing environment, thus a 
standard protein production in bacteria would not produce a proper folded protein. 
After using various systems with different parts of the extracellular domain of Notch,
we ended up producing EGF10-13 in little quantities with bacteria under special 
conditions. To assure that these bacteria fold the protein properly, a signal peptide was
attached to the protein so that it is secreted to the periplasmatic space. In addition, a 
disulfide isomerase was co-secreted and the growth medium was supplied with L-
Acetylcysteine as a redox buffer (see materials and methods). Under these conditions
oxidative protein folding should work properly (Maskos et al., 2003). 
At the moment we have 0.5 mg of EGF10-13 protein which is the required amount for
the SELEX procedure and we are ready to ship the protein for aptamer production. 
57
Results
Figure 4.14 The SELEX procedure
The SELEX procedure starts with a library of random sequences of single stranded RNA or DNA
molecules with a length between 20 and 40 nucleotides. Theoretically, a library comprises around 1024
different sequences.
Such a library is incubated with the target of interest at a given temperature in a specific buffer. The
bound population is then eluted, amplified by PCR and, after strand separation, again incubated with the
target. After 8 to 15 cycles, affinity saturation is achieved and the selected aptamers can easily be 
sequenced and synthesized.
Picture from (Jayasena, 1999). 
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2.5. Discussion 
During the last years much has been revealed of the complex genetic network and its 
intriguing interplay that controls eye development. Strikingly, many genes and their 
interactions that are involved in eye development apparently are conserved throughout
the animal kingdom (reviewed by (Treisman, 1999; Kumar, 2001). Mutations in the 
transcription factor Pax-6 - a master control gene of eye development (Gehring and 
Ikeo, 1999) - are responsible for Aniridia in humans and Small eye in mice (Hill et al.,
1991). Mutations in the Drosophila Pax-6 gene eyeless are responsible for an eyeless 
phenotype (Quiring et al., 1994a). Furthermore, the mouse Pax-6 protein is able to 
induce ectopic eyes in Drosophila, which shows the high degree of functional 
conservation of the Pax-6 gene between species (Halder et al., 1995). Conversely the 
Drosophila eyeless is able to induce ectopic eye structures when ectopically expressed 
in Xenopus embryos (Onuma et al., 2002). In the ribbonworm Lineus Pax-6 is not only 
important for eye development but also for maintenance and regeneration of the adult
eyes (M.Tarpin, pers. Comm.). Notch, which lies genetically upstream of Pax-6
(Kurata et al., 2000; Kumar and Moses, 2001), is crucial for eye development in 
Drosophila and vertebrates and Notch-1 as well as Pax-6 are expressed in the retina of 
adult mice and humans (F. Hafezi, pers. Comm.). 
So far neither in vertebrates nor in Drosophila much is known about the molecular
mechanisms that are necessary for the maintenance and eventually the regeneration of 
the retina.
We hypothesize that the Notch pathway and the transcription factor Pax-6 are both
involved in maintenance and regeneration of the adult Drosophila and vertebrate 
retina. Thus having a soluble Notch ligand that could activate Notch from the outside
of the cell would be a promising tool to activate the receptor, increase the transcription
of Pax-6 and thereby prevent retinal degeneration. 
Recently a single point mutation in the human protein EFEMP1 has been identified 
that causes the retinal dystrophy Malattia Leventinese (Stone et al., 1999). Due to the
similar phenotype of ML and the frequent age-related macular degeneration, ML
appears to be an early onset form of AMD (Marmorstein et al., 2002). The structural 
similarities between EFEMP1 and the so far known Notch ligands makes us believe
that this human protein might be a soluble Notch ligand and that the disease is a result
of an inappropriate activation of the Notch pathway in the retina.
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In our work we wanted to test whether EFEMP1 is indeed a Notch ligand and if not, 
whether the fly is an appropriate tool to study the molecular function of this human
protein.
In silico structure comparison of EFEMP1 with Notch ligands 
All Notch ligands known so far that are able to activate Notch share several properties. 
First they all are single pass transmembrane proteins. EFEMP1 is a protein of the 
extracellular matrix secreted from the RPE and does not comprise a transmembrane
domain. Different studies could not clarify whether attachment to the membrane is 
crucial for a ligand to be able to activate the Notch receptor. Truncated, soluble forms 
of Serrate and Delta have been shown to act as antagonists of Notch signaling in 
Drosophila (Fleming et al., 1997; Hukriede and Fleming, 1997; Hukriede et al., 1997; 
Sun and Artavanis-Tsakonas, 1997; Qi et al., 1999). Other secreted forms of either 
Delta1 or Jagged1 have been used as activators or repressors of Notch signaling in 
mammalian cell types (Li et al., 1998; Varnum-Finney et al., 1998; Wang et al., 1998;
Qi et al., 1999; Sestan et al., 1999; Morrison et al., 2000; Ohishi et al., 2000). Recent 
in vitro studies suggest that the ability of Delta to activate Notch is related to its 
multimerization (Hicks et al., 2002).
Taken together, further investigations are necessary to answer the question if soluble
proteins are able to activate the Notch receptor and how soluble Notch agonist in 
general look like. 
A second property which all Notch ligands share is an array of tandem repeated EGF
domains. EGFs are cysteine rich domains that are intramolecularly linked by
disulphide bridges and are involved in protein-protein interactions. EGF repeats are 
common in extracellular matrix proteins and are present in the fibulins, in crumbs and 
other proteins mostly involved in cell adhesion and cell to cell signaling. 
The third and most important feature common among Notch ligands is their DSL 
domain that is located near the aminoterminal end through which the ligand interacts 
with Notch (Rebay et al., 1991; Fitzgerald and Greenwald, 1995; Shimizu et al., 1999).
The name DSL represents Delta, Serrate and Lag-2, the Drosophila and C. elegans
Notch ligands in which this domain was described first. By comparison the DSL 
domains of all so far known Notch ligands from different species a consensus sequence 
of 11 amino acids was found (Lissemore and Starmer, 1999). When we analyzed the
60
Discussion
sequence of EFEMP1, we found a putative DSL domain that shows identity to 8 amino
acids of the consensus sequence. From the amino acid sequence it is difficult to predict
whether this is a true DSL domain. It could also act as a further EGF repeat since DSL 
domains are related to EGF repeats due to their high content of cysteines. However, as
an EGF repeat this DSL domain of EFEMP1 would be most closely related to DSL 
domains among all EGF repeats. 
In conclusion, EFEMP1 is a protein of the extracellular matrix secreted from the RPE
with high similarities to Notch ligands.
Overexpression experiments 
Upon over-expression of a Notch ligand in Drosophila we expected phenotypes like 
overgrown eyes or truncated wings and legs depending on the stage and tissue where 
the protein is expressed. In all our experiments where we over-expressed EFEMP1 and 
EFEMP1Arg345Trp either alone or together with human Notch-1 or a chimeric Notch in 
different developmental stages and tissues we did not see any EFEMP1/
EFEMP1Arg345Trp specific phenotype. Further over-expression experiments using the 
putative fly homologue of EFEMP1 did also fail to produce a mutant phenotype in the 
fly. By interpreting these results it has to be kept in mind, that most of the Drosophila
genes do not exhibit any change of morphology upon over-expression. 
Another reason for the lack of mutant phenotypes could be the fact that the mammalian
protein might not be secreted to the extracellular matrix in insect cells and therefore
can not interact with its receptor. However, for the following reasons we do not think 
that this is the case: First, when running EFEMP1 that was purified out of the
supernatant of an insect cell system on a SDS gel in non-reducing conditions, we see
slow migrating bands as we would expect it from a protein, that has properly formed 
EGF domains.
Second, signal peptides of insect and mammalian proteins look very similar and all 
mammalian secretion signals that were tested by Invitrogen functioned properly in 
insect cells (Invitrogen, 2002). 
Third, antibody staining for EFEMP1 upon expression in imaginal discs shows an 
accumulation of the protein that is compatible with a proper secretion of the protein to 
the extracellular matrix.
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Out of these reasons we assume that EFEMP1 is processed normally in the fly but that
the protein does not provoke a dominant phenotype upon over-expression. 
Assays to detect interaction with the Notch receptor 
Posttranslational modifications like glycosylation, phosphorylation and others are very 
common in vertebrate proteins. In addition, tertiary structures formed by extracellular 
matrix proteins are different from that of intracellular proteins due to their oxidizing
environment (eg. disulfide bonds). In our pull-down experiment the proteins were 
synthesized by bacteria and thus probably not correctly processed. Therefore we can 
not exclude that EFEMP1 does not interact with Notch in the assay since no correctly
folded EFEMP1 was produced in bacteria and hence the protein lacked appropriate 
efficacy. Still it is a fast and easy method to detect protein-protein interactions based 
on their primary structure.
In a second in vitro experiment the proteins were synthesized by vertebrate cells. 
Hence we expected all modifications to occur properly. A luciferase reaction was used 
to detect Notch activation: activation of the receptor by a ligand results in a measurable
light formation in this assay.
Unfortunately, EFEMP1 also did not induce this system. Therefore our results suggest
that EFEMP1 is not an agonist of the Notch pathway, at least not as a monomer or a
homo-multimer.
In an in vivo assay we finally tried to detect alterations of the Notch pathway. Here
activation of Notch becomes visible as a strong blue staining on imaginal discs. Due to 
the lacZ reporter, this is a sensitive method to detect activation or repression of the 
signaling cascade.
When we tested EFEMP1 we could not observe any effect on the receptor with this
assay. Still, as a human protein it is conceivable that although the high sequence
similarity between human and Drosophila Notch, EFEMP1 is not able to interact with 
Drosophila Notch. Therefore, we still have to test the putative EFEMP1 homologous
protein of Drosophila within this assay.
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Conclusion and outlook 
With the so far used methods we could not get any evidence that EFEMP1 is indeed a
Notch ligand despite its high sequence homology to known Notch ligands. Our over-
expression experiments show that EFEMP1 and EFEMP1Arg345Trp do not have a 
dominant effect - neither on eye development nor on the retina of aging flies.
The work presented so far is limited with respect to the fact that we only tested for
gain-of-function properties of EFEMP1. Another means to elucidate the function of a 
gene is to study its loss-of-function. Up until very recently we did not have any null 
mutation of the putative Drosophila homologous gene of EFEMP1 and making a
knock-out is difficult and time consuming in flies. A method that became established 
for flies is the conditional knock-out of genes by RNA interference (RNAi) (Kalidas 
and Smith, 2002). At the moment we are using this method to block protein synthesis
of the Drosophila homologue of EFEMP1. If the conditional knock-down of this gene 
results in a mutant phenotype we will be able to find out which mechanism is disrupted 
and can furthermore try to rescue this phenotype by expressing human EFEMP1
combined to the RNAi against the fly gene to proof that EFEMP1 can functionally 
replace its fly homologue.
In situ hybridization shows that the putative Drosophila EFEMP1-homologue is 
expressed in the developing eye. Using antibodies we are about to detect where the
protein is located on the cellular level in the developing and adult eye of the fly. If this 
Drosophila gene similar to EFEMP1 finally turns out to be homologous to EFEMP1
not only regarding its structure but also exhibits a similar function, we expect it to be 
expressed and secreted to the extracellular matrix surrounding the photoreceptor cells 
of the compound eye. 
If we are able to elucidate the function of this gene in Drosophila, we can draw 
conclusions on the function of EFEMP1 and probably get more ideas of what kind of 
experiments will be appropriate to elucidate the pathomechanism of Malattia 
Leventinese and consequently AMD. 
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Summary
3. Molecular genetic analysis of a sine oculis enhancer
3.1. Summary
The sine oculis (so) gene is important for the development of the entire visual system 
of Drosophila melanogaster. so shows homology to the vertebrate Six-gene family that
is characterized by genes encoding a Six domain and a Six-type homeodomain. Like
twin of eyeless (toy), eyeless (ey), eyes absent (eya), and dachshund (dac), so belongs 
to a network of genes that by complex interactions render the genetic background of 
eye development.
An eye specific enhancer fragment of the so gene (so10) has previously been shown to 
be directly regulated by ey and toy during compound eye development. It is sufficient
to rescue the compound eye by driving so in a so-mutant background but only in 
combination with the adjacent sequences (so9), so10 re-establishes both, the eye- and
the ocelliless phenotype of so1 mutant flies.
We studied the regulation of the so9 enhancer further and found that a fragment as
small as 27bp (soAE) is sufficient for so9 mediated expression. In addition, we show
that SO itself binds and regulates soAE. The resulting auto-regulatory loop is 
important for ocellar development.
By systematic analysis of the DNA-protein interactions between soAE and SO we 
identified the most important nucleotides for this interaction. Using the emerging
consensus for SO-DNA binding we performed a genome wide search for putative so-
target sites and have thereby been able to identify ey and hedgehog (hh) as putative
targets of so. Our results, by providing an additional example, strengthen the general
assumption that feedback loops among the genes of the retinal determination network 
are crucial for proper development of eyes and ocelli. 
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3.2. Introduction
The Drosophila visual system consists of two compound eyes and three ocelli, which 
are simple eyes located on the adult vertex (Stark et al., 1989). Both types of optical
organs develop from a small number of cells that are set aside during development in 
the early embryo. These cells form the eye part of the eye-antennal imaginal disc and 
proliferate during the larval stages. Finally, the compound eye emerges from the
central part of the eye imaginal disc whereas the ocelli develop from the anterior-
medial region. The compound eye in Drosophila consists of a precisely organized array
of approximately 750 ommatidia, each containing eight photoreceptor neurons and 
twelve accessory cells. The ommatidia begin to form in the early 3rd instar larva, when 
the morphogenetic furrow (MF), a wave of pattern formation marked by an indentation,
moves across the eye disc from posterior to anterior (reviewed by Wolff and Ready,
1993). Although committed to retinal fate, cells anterior to the furrow are still 
undifferentiated, whereas cells posterior to it are sequentially recruited into ommatidial
clusters undergoing retinal differentiation (reviewed by Treisman and Heberlein,
1998).
Determination of the eye primordium requires several nuclear proteins that are known 
to act as transcriptional regulators. The Drosophila Pax6-gene eyeless (ey) was the first
gene shown to display the capacity to induce ectopic eye morphogenesis upon ectopic
expression (Halder et al., 1995). A second Drosophila Pax6-gene, twin of eyeless (toy),
like ey encodes a protein with two DNA-binding domains (Czerny et al., 1999).
Further genes in early eye determination are eye gone (eyg) which also shows
homology to Pax6 (Jun et al., 1998; Chao et al., 2004; Dominguez et al., 2004), sine
oculis (so), a homeobox gene (Cheyette et al., 1994), eyes absent (eya) and dachshund
(dac) both encoding nuclear proteins (Bonini et al., 1993; Mardon et al., 1994). 
Analyses of the expression patterns of these genes combined with genetic approaches
have revealed a complex genetic regulation network during compound eye
development. toy is the first of the mentioned genes to be expressed during 
embryogenesis and activates ey in the eye primordium (Czerny et al., 1999). so is 
required later for the development of the entire visual system, including the compound
eyes, the ocelli, the optic lobe of the brain and the larval photoreceptors designated as 
Bolwig’s organ (Cheyette et al., 1994; Serikaku and O'Tousa, 1994; Pignoni et al., 
1997). eya expression comes up later in the compound eyes and can be found in the
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ocelli-specifying region in third instar eye imaginal discs. Recently, eya has been 
shown to have protein phosphatase activity (Li et al., 2003; Tootle et al., 2003). so and
eya are both required for compound eye and ocelli formation, since the according
mutants lack both visual systems (Zimmerman et al., 2000). so, eya and dac have been 
shown to be regulated by ey (Halder et al., 1998a; Niimi et al., 1999; Zimmerman et 
al., 2000). SO and DAC have been proposed to function as cofactors for EYA, and 
genetic studies in Drosophila have demonstrated synergistic interactions between so,
eya and dac during eye development (Chen et al., 1997; Pignoni et al., 1997). The
respective protein complexes feed back on ey expression and eya and dac, like ey and 
toy are capable of inducing ectopic eye morphogenesis (Bonini et al., 1993; Bonini et
al., 1997; Pignoni et al., 1997). 
Although much knowledge has been gathered during the last years about the complex
genetic network that orchestrates eye development, only a small number of observed 
regulatory interactions have been analyzed down to the level of DNA-protein
interactions. Analysis of further components controlling expression patterns of genes
involved in early eye development should therefore provide important details on the
genetic hierarchy that mediates eye specification and may help to identify direct targets 
of the known eye specification genes.
Among the already described direct interactions toy has been shown to induce ey
expression by an eye-specific enhancer in embryonic eye precursor cells, but not
during larval stages in the later emerging eye imaginal disc (Czerny et al., 1999). ey on 
the other hand together with toy directly regulates so expression by an eye specific 
enhancer which is deleted in the so1 allele (Niimi et al., 1999; Punzo et al., 2002).
Further ey-regulated, eye specific enhancers could be identified by genomic deletions 
within the eya gene-locus (Zimmerman et al., 2000).
In this study, we address the regulatory potential of a previously described so7
enhancer fragment during ocelli morphogenesis. So7 represents the DNA-fragment
which is deleted in the so1 mutation and contains the ey and toy regulated enhancer
element so10. We show that a 27bp fragment within so7, soAE, is sufficient do expand 
expression of a reporter gene to the ocellar region when fused to the so10 enhancer. 
Furthermore we show that soAE is a direct target of so in compound eye and ocelli 
development and that the autoregulatory feedback of so on its own expression is 
needed for the ocelli specific expression of so.
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By analyzing the sequence specificity of SO-binding in more detail, we were able to 
identify the nucleotides specifically important for SO-soAE interaction. Using the
thereby emerging cis-regulatory signature for so-dependent regulation we performed a 
genome-wide search for further potential so-target genes. Sequences that fit our
selection criteria were identified in the ey and hedgehog (hh) loci. We show that both
of these genes contain eye specific enhancers that are directly regulated by so. Our
results emphasize the importance of autoregulatory feedback loops in morphogenesis 
and development.
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3.3. Results 
3.3.1. Defining a minimal eye/ocelli specific enhancer of the so 
gene
A 1.6 kb enhancer fragment (so7, Fig.1A) spanning the entire genomic region deleted 
in so1 is able to recapitulate the expression pattern of so in 3rd instar eye imaginal discs 
when driving a lacZ reporter gene (Fig 1B). Furthermore, so7 is able to completely
rescue the eyeless and partially the ocelliless phenotype of so1 mutant flies when
driving the so gene (Punzo et al., 2002).
So10 (400bp) and so9 (1,2 kb) (Fig. 1A) are subfragments of so7. so10 mediates
expression in the compound eye part of 3rd instar eye-antennal imaginal discs and
contains the previously described ey and toy specific binding sites (Fig. 1C). These 
include five binding sites bound by toy. Three of these are also binding sites for ey and 
are important for compound eye development whereas the two toy specific sites are 
required for ocelli development (Niimi et al., 1999; Punzo et al., 2002). Consistent 
with its expression pattern, so10 is able to rescue the eyeless phenotype but not the 
ocelliless phenotype of so1 mutant flies (Punzo et al., 2002).
so9 mediated expression appears at the posterior margin of the eye disc (Fig. 1D). 
When combined with so10, so9 provides additional transcriptional input to expand the 
expression to the ocellar region. 
Trans-acting factors that bind the cis-regulatory so9 element and cooperate with toy to 
confer expression in the ocellar region were unknown when this work was started. In 
order to locate the binding sites of such additional transcription factors we first aimed
at the isolation of the smallest version of so9 that still would be able to drive
expression of a LacZ reporter to the ocellar region of eye imaginal discs when 
combined with so10 (Fig. 1A). 
Our search resulted in the identification of a fragment as small as 27bp (Fig1A 
Fragment 21) that will be referred to as soAE in the following (sine oculis
autoregulatory element).
The expression pattern mediated by a combined so10-soAE-element was 
indistinguishable from expression mediated by so7 (Fig. 1A Nr. 14), whereas soAE 
alone resembled the expression pattern of so9 (Fig. 1A Nr. 21). Therefore soAE
contains all regulatory elements that are sufficient for so9 mediated expression. Further
evidence for the functional relevance of this sequence came form the comparison of 
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D.melanogaster and the genomes of other Drosophila species in which the soAE 
sequence shows a high degree of conservation between 6 different species (see
appendix).
3.3.2. sine oculis is able to recognize its own enhancer 
In soAE three sequence motifs can be found, that are reminiscent of well known 
transcription-factor binding-sites. These are a motif related to the Pax6-consensus-
binding site (Epstein et al., 1994), a TAAT-motif that is a hallmark of most
homeodomain recognition sequences and a GATA-motif. We mutated these sites, 
respectively, and tested the according fragments (so10-mutPAX, so10-mutHD, so10-
mutGATA) for the resulting expression patterns. 
so10-mutPAX mediated expression was indistinguishable from the so10-soAE
expression pattern (Fig. 2C). Conversely, mutating the putative homeodomain binding 
site (so10-mutHD) or the GATA sequence (so10-mutGATA) resulted in loss of 
reporter gene expression in the ocellar region (Fig. 2A, 2B).
We then oligomerized (4 times) soAE, to boost its expression pattern. As a result, an 
expression signal became apparent posterior and in front of the MF (Fig. 2E) as well as 
in the optic lobe (data not shown). However, 4xsoAE was not able to drive expression
in the ocellar region. Additional copies of soAE did not lead to a further strengthened
expression. Expression of 10xsoAE, for example, appears blotchy and weaker in the
eye disc than expression of 4xsoAE (Fig. 2F). 
Since the expression pattern of 4xsoAE is reminiscent of so-expression in the eye disc,
we hypothesized so itself to be the soAE regulating factor. Both expression patterns 
show signal in the optic lobe as well as posterior, within and in a few cells in front of 
the MF. The only difference is the ocellar expression of so, which cannot be seen using 
the 4xsoAE reporter construct. 
The idea that so itself is the soAE binding factor was further supported by a previous 
work, where Hazbun et al. showed that SO binds to (C/T)GATA in vitro (Hazbun et 
al., 1997), a motif that is present in soAE (Fig.4C nt. 7-11). 
To experimentally determine whether the expression pattern of the mutated fragments
correlates with the ability of these fragments to bind SO in vitro we performed EMSA
experiments. SO protein was able to shift radiolabeled mutPAX but failed to bind to 
mutHD and mutGATA DNA-fragments (Fig. 2H). 
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These results in combination with our in vivo data strongly suggest that so itself is 
responsible for the ocellar specific expression of so10-soAE. 
3.3.3. so10-soAE-LacZ and so7-LacZ are not expressed in the 
ocellar region of so2 mutant flies 
To further test this hypothesis, we moved on to a genetic approach. so2 is a 
hypomorphic allele that originated as a spontaneous partial reversion of so1 (Lindsley 
and Zimm, 1992). Different from so1 adult flies which completely lack compound eyes 
and ocelli, so2 flies develop compound eyes that range from normal appearance to 
slightly reduced shapes but still lack ocelli in total. In so2 /so1 flies, eyes are of 
intermediate size (Heitzler et al., 1993). Due to the common origin and the genetic 
interaction of these two alleles, we tested if there is a mutation in so2 flies that affects 
the genomic so9/so10 sequences. Using PCR on genomic so2-DNA, we found a 
deletion of 1.2kb that indeed affects so7. We further confirmed this result by southern 
blot (data not shown). The deletions of so1 and so2 partially overlap (Fig. 1A) and in 
so2, 4 of the 5 previously described Pax6-binding sites are missing (Punzo et al., 
2002). In fact, both binding sites solely recognized by TOY are deleted. According to 
Punzo et al, these toy specific binding sites within the so10 enhancer fragment are
required for ocelli development. The sequence representing so9, that contains the soAE 
fragment, appeared not to be affected by the so2 deletion.
In a next step we took advantage of so2 mutant flies to test whether the cis-regulatory
potential of soAE depends on SO protein in vivo. Therefore we analyzed so10-soAE 
mediated expression in the ocellar region in so2 mutant flies. As expected, so10-soAE-
LacZ expression is lost in the ocellar region of so2 mutant flies (Fig. 3D) supporting 
the idea of so being required for the ocelli specific expression of so10-soAE further. 
The absence of reporter gene expression can not be explained by a loss of ocelli
specific precursor cells as eya expression, which represents a marker for this specified
cell population, is detectable in so2 mutant flies in the prospective ocellar region (Fig. 
3E).
Taken together, toy and so binding to so10 and soAE, respectively, seem to
cooperatively drive so-expression in the ocellar region of 3rd instar eye discs.
To further examine the hypothesis that so-autoregulation is important for ocelli
development and as a control, we tested so7-LacZ expression in so2 mutant flies. so7
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was shown to be sufficient to completely rescue the eyeless and to partially rescue the 
ocelliless phenotype of so1 mutants when driving so (Punzo et al., 2002). Like so10-
soAE-LacZ, so7-LacZ expression is lost in the ocellar region of so2 mutant flies (data
not shown). To do the reverse experiment we mutated the SO binding site of so7 and 
looked at the expression pattern in a wt fly (Fig. 1A nr.22 and Fig. 1E so7mut).
So7mut-LacZ expression is hardly detectable in the ocellar region and resembles
expression of fragments nr7 and nr11 (Fig. 1A,E). These data strongly suggests that
feedback of so on its own enhancer is needed for ocelli development.
3.3.4. 4xsoAE is not expressed in so3 clones 
To assess whether soAE is a target of so also in the compound eye part of the eye disc,
we tested the expression of the 4xsoAE reporter construct in cells homozygous for so3,
a null allele of so (Cheyette et al., 1994). so3 mutant cells, however, tend to 
overproliferate, fail to differentiate into neurons and subsequently die (Pignoni et al.,
1997). Hence, to be able to analyze reporter gene activity in non-dying cells within so3
clones we tested them for eya expression. eya expression is considered to mark the
healthy, differentiating cells that normally would express so and eya together, but lack
so due to the so3 mutation, for the following reasons: First, so and eya both are targets
of ey and show the same expression pattern in 3rd instar eye discs (Halder et al., 1998b; 
Niimi et al., 1999; Bui et al., 2000b). Both are expressed in a few cells anterior to the 
MF, within the MF, and in the differentiating photoreceptors posterior to the MF 
(Curtiss and Mlodzik, 2000). Second, SO and EYA proteins form a complex that 
works as a transcriptional activator when the proteins are coexpressed. (Pignoni et al., 
1997; Silver et al., 2003). Third, so1 mutant eye discs still express eya whereas in eya1
mutants, expression of so is lost (Halder et al., 1998b). Finally, so can be induced by 
eya in 3rd instar eye imaginal discs (Curtiss and Mlodzik, 2000). For these reasons we
assume eya-positive-cells of 3rd instar eye discs to also express so during normal
development. Therefore only the reporter gene expression of eya-expressing cells 
within the clones was considered in our assay. In fact, in eya-expressing cells within
so3 clones, expression of the 4xsoAE reporter construct is lost (Fig.3H,I). This strongly
suggests, that SO protein in general is needed to activate the soAE element in the eye-
field.
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3.3.5. 4xsoAE-LacZ is induced in ectopic eyes and in cell culture 
To further analyze whether soAE is a general in vivo target of SO we tested reporter
gene activity as a result of ectopic eye induction. so on its own is not able to induce
ectopic eyes. In contrast, eya alone, synergistically strengthened by so, is sufficient to 
induce ectopic eye development on antennae, wings and legs (Pignoni et al., 1997).
We induced ectopic eye development by combining a dpp-GAL4 driver with UAS:so,
UAS:eya or both of them and tested whether the reporter construct 4xsoAE-LacZ was 
induced ectopically. As expected, ectopic so alone does not result in reporter gene
activity wheras eya alone or eya combined with so in a synergistic manner is able to 
activate the reporter construct in wing discs (Fig. 3A-C). 
In another in vitro approach, we took advantage of Drosophila S2 cells to address
whether SO and EYA proteins work as a complex on soAE to induce transcription. 
Consistent with the in vivo data, our in vitro results using S2-cells show that SO, which
has DNA binding properties but lacks a transactivation domain, on its own is not able 
to activate soAE mediated LacZ expression (Fig. 3J). Likewise, EYA which contains a
transactivation domain but lacks DNA binding properties also fails to induce
transcription in S2 cells when alone (Fig. 3J). Only when coexpressed, SO and EYA 
cooperatively work as transcriptional activators on soAE (Fig. 3J).
Interestingly, both SO and EYA mediate weak transactivation when the oligomerized
mutated sites mutHD and mutGATA are used (Fig. 3J), despite the fact that these sites 
do not show any expression pattern in vivo (Fig. 2A,B). 
3.3.6. Defining a consensus sequence for SO - DNA interaction 
To date, there is only one direct target of so described in Drosophila, which is the 
Runx class transcription factor lozenge (lz) (Yan et al., 2003). Consistent with a
previous in vitro study that addressed the DNA specificity of the SO homeodomain
(Hazbun et al., 1997), the authors show that the sequence (C/T)GATA plays a crucial 
role in SO-DNA interaction. Another study reports of SO together with EYA being 
able to transactivate by a AREC3/Six4 binding site in cell culture. This motif,
however, diverges from the C/TGATA-motif (for sequence see Fig. 4C) (Silver et al., 
2003).
Our identified soAE fragment harbors CGATA and therefore is consistent with the SO 
binding consensus of the lz promotor. In our experiments, however, also mutations
upstream of this GATA core motif (Fig 4C nt. 8-11) were not only able to abolish 
73
Results
expression of the reporter construct in vivo, but they also impaired the capability of SO 
to shift DNA fragments in EMSA. This observation made us believe that additional 
sequences upstream of the GATA motif are as well necessary for SO binding to its
target DNA-sequence.
Therefore we decided to elucidate the sequence specificity of SO-DNA-binding by 
analyzing a systematic series of point mutations for their effect on protein-DNA
complex formation (Fig. 4A)
These in vitro experiments revealed a stretch of 13 nucleotides to be important for
protein-DNA interaction of SO. There are three nucleotides G, A, A at positions 1, 4,
9, respectively (Fig. 4A lanes 9, 12, 17 and Fig. 4C nt. 1, 4, 9), that appear to be most
important for the interaction. These nucleotides show the strongest effects upon 
mutation and are missing in constructs so10-mutHD and so10-mutGATA as well.
These nucleotides are also found in the AREC3/Six4 binding site. Therefore, there is 
strong evidence for these nucleotides to be especially important for soAE-mediated
reporter gene expression in vivo (Fig. 2A,B). 
3.3.7. Genome-wide search for potential sine oculis target genes 
Combining our in vitro data on the autoregulatory element with the known so-target-
sequence of lz and the AREC3/Six4 binding site, we defined the consensus sequence:
GTAANYNGANAYC/G necessary for SO-protein binding to DNA. This consensus 
sequence was taken as a basis for scanning the Drosophila genome for similar sites 
(see experimental procedures). 1632 putative so targets emerged from this survey. Out 
of the affected genes several candidates are already known to be involved in eye 
development. In the following we will describe two of these genes that we picked for
further analysis: ey and hh.
3.3.8. eyeless is a direct target of so
The first soAE similar element that caught our attention was located within the 
previously described eye specific enhancer of the ey gene (Czerny et al., 1999; Hauck 
et al., 1999). A positive feedback loop already has been postulated due to the fact that
ey is induced in ectopic eye development upon coexpression of so and eya (Pignoni et 
al., 1997). Furthermore, the ability of so and eya to induce ectopic eyes is lost in ey2
mutants (Pignoni et al., 1997). In ey2 mutant flies, the previously mentioned eye 
specific enhancer of ey is disrupted by insertion of a transposable element (Quiring et 
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al., 1994b) (see also Fig. 5A). These experiments genetically show that so and eya are 
able to feedback on ey and that this feedback loop relies on the eye specific enhancer
of the ey gene. A direct interaction of so, eya and the ey-enhancer, however, has not
been shown yet. 
The fact that the potential so target site within the eye specific enhancer is perfectly
conserved between D. melanogaster and D. pseudoobscura and two other Drosophila
species (see Appendix), encouraged us to perform more assays to obtain evidence for a 
direct interaction.
First we showed that oligos containing this sequence are strong competitors for the 
binding of SO to soAE in EMSA, whereas this competing potential is lost when the
GAT core (Fig. 4C nt. 8-10) of the sequence is mutated (Fig. 4B, eyeless and eyeless
mut).
We then compared the expression pattern of different mutated versions of a 160bp 
fragment, comprising the eye specific ey-enhancer, driving a LacZ reporter (sequences 
shown in Fig. 5A). The wt enhancer mediates expression posterior to the MF, most
prominent at the posterior margin (Fig. 5B) (see also Hauck et al. Fig. 4D) (Hauck et
al., 1999). By mutating the Pax6 sites, expression in the eye disc is reduced to the 
posterior margin (Fig. 5C) (see also Hauck et al. Fig. 4F) (Hauck et al., 1999). 
Mutating both, the so site and the Pax6 sites further reduces expression in the eye disc 
(Fig. 5C). The fact, that we still see weak expression at the posterior margin in some of
the transgenic lines harboring B4M-SOmut-LacZ might be explained by residual
activity of the mutated sites or another yet unknown cis-acting element within this ey-
enhancer. Nevertheless, the genetic and in vitro data suggest that so directly binds the
eye specific enhancer of the ey gene. 
3.3.9. hh is a direct target of so
hh is a secreted signaling protein that plays an important role in patterning the 
Drosophila eye field. Many lines of evidence suggest that hh signaling is required for 
the initiation and the propagation of the MF. Accordingly, hh is expressed at the
posterior margin of the eye imaginal disc prior to photoreceptor differentiation and in 
all cells posterior to the MF during its progression (Borod and Heberlein, 1998). Loss 
of hh function blocks initiation of the MF and impedes its progression (Borod and 
Heberlein, 1998). Posterior margin clones of a null allele of smoothened (smo), the 
cell-autonomous receptor of hh signaling, lack differentiated photoreceptors 
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(Greenwood and Struhl, 1999; Curtiss and Mlodzik, 2000). Conversely, ectopic hh
expression anterior to the MF gives rise to a progressing ectopic MF (Heberlein et al., 
1995; Pignoni and Zipursky, 1997). 
so and eya also have been shown to be required for initiation and propagation of the
MF (Pignoni et al., 1997) and both are expressed at the posterior margin prior to 
initiation and later in front of the MF (Bonini et al., 1993; Serikaku and O'Tousa,
1994). Furthermore, ectopic MFs are found in ectopic eyes induced by so together with 
eya (Pignoni et al., 1997). These data suggest, that a feedback loop between hh and
so/eya might influence the proper initiation and propagation of the MF. Consistent
with that, hh fulfills our criteria to be a putative SO target. Both sites found within the
hh locus show almost perfect conservation between 7 Drosophila species (see
Appendix) and are able to compete for SO binding in EMSA (Fig. 4B, hh first, hh
second). In addition, we found these sites to be located within an area that is deleted in 
the bar-3 allele. bar-3 is a weak hh allele affecting adult flies. The according deletion
can be found in the first intron of the hh gene (Mohler, 1988; Lee et al., 1992). The
predominant phenotype of bar-3 is a reduction of eye facets. Therefore the deletion
leading to the bar-3 allele may affect an eye specific enhancer of hh (Renfranz and 
Benzer, 1989). This idea is supported by the observation of Kango-Singh et al. that in 
bar-3 mutant flies (hh1), targeted expression of ey fails to induce ectopic eyes (Kango-
Singh et al., 2003). 
We chose to clone 1.4kb out of the bar-3 deletion that are encompassing the two so
sites and again ligated this fragment to the lacZ reporter gene. Expression of the 
resulting bar-3-LacZ construct is found exclusively in the eye disc in cells posterior to 
the MF (Fig. 6B) in perfect agreement with the observation of Lee et al. that hh is 
expressed in differentiating photoreceptor cells (Lee et al., 1992). In a next step we 
mutated the two SO binding sites by replacement of GAG with CCC and GAT with 
CCC in the first and the second SO binding site, respectively (Fig. 6A hh bar-3
SOmut). The resulting construct has lost its capability to induce LacZ expression. Only 
in a few of several observed transgenic lines, weak expression in the same pattern like
the wt construct is detectable (Fig. 6C). This residual activity is likely due to a weak
interaction of SO with the mutated binding sites similar to what we see in our cell 
cultutre assays (Fig. 3J). When we test a construct in which the first SO binding site is 
76
Results
deleted and the second is mutated this residual expression is lost (Fig 6A hh bar-3 ?5’,
6D).
These results show that the two SO binding sites within the first intron of the hh gene 
are functional in vivo and sufficient to mediate expression reminiscent of the known hh
expression pattern in a late 3rd instar eye imaginal disc. This strongly suggests that hh
is directly regulated by so.
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3.4. Discussion 
3.4.1. so autoregulation is essential for ocelli development 
so gene activity is crucial for proper development of the entire visual system of
Drosophila melanogaster, including the larval visual system (Bolwig’s organ), the 
optic lobe, the compound eye and the ocelli. Starting from research that was done on 
an eye specific enhancer of so and identified ey and toy to regulate so-expression, but 
considering that these factors alone are not sufficient to establish the natural so-
expression in the ocelli-region, we tried to find additional factors that regulate so-
expression in ocelli development.
We were able to show that so itself, in cooperation with eya, forms an autoregulatory
feedback-loop. Since auto-regulation can never initiate expression of a gene, the 
initiation of so-expression in the ocelli region must be triggered by other means. Most
probably, a dynamic expression pattern of so initiated and regulated by ey and toy can 
explain, how so-activity emerges in a cluster of cells, that later in development gives 
rise to the ocelli. One first hint is given by the expression dynamics mediated by the
so10-enhancer-element: so10, which is activated by ey and toy in the compound eye 
field, mediates expression in early 3rd instar larvae all over the eye disc (Punzo et al.,
2002). Later in development, however, expression mediated by so10 is lost in the 
ocellar region. Therefore, initiation of so expression in the early 3rd instar stage most
probably is mediated by ey and toy throughout the eye disc including the ocellar 
precursors. Later, after this first induction by the activity of the so10 enhancer, so in
the ocelli region can maintain its own expression - cooperatively with toy and eya - 
regulating itself.
Due to this consideration, one would expect so to be expressed all over the eye disc in 
3rd instar stages, which is, however, not the case. The potential of so to also mediate
gene-repression might explain this observation. It was previously proposed that so may
function as both, a transcriptional activator and a repressor dependent on the context-
specific expression levels of particular cofactors (Silver et al., 2003). In a complex
with EYA, SO works as transcriptional activator. In contrast, SO is expected to 
function as a transcriptional repressor when interacting with the transcriptional
corepressor groucho (gro) (Silver et al., 2003). Therefore, eya and gro seem to 
dominate the quality of a so-autoregulatory feedback-loop. This explanation is
supported by the fact, that EYA protein can only be found in the ocellar region itself,
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no EYA is present in the proximity of these cells. This idea is further strengthened by 
the fact that eya4 mutants show an eyeless and ocelliless phenotype (Zimmerman et al., 
2000) whereas gro1/gro1 flies have enlarged and partially fused ocelli (Price et al., 
1997). Therefore, to elucidate the mechanisms that control so expression in ocelli, 
additional studies on eya and gro are required. 
Nevertheless, so/eya and toy are unlikely to be the only transcription factors that bind 
to the ocellar specific enhancer of so, since the enhancer of the ey gene contains
binding sites for both factors but ey cannot be found to be expressed in the ocellar 
region. Further studies will need to identify the entire transcriptional machinery that
regulates so and consequently ask for eya regulation to understand the expression 
pattern of so completely.
Amazingly, 4xsoAE mediated expression in the compound eye and in the ocellar area 
is different despite the fact that cells of both tissues express so and eya: 4xsoAE-LacZ
is solely induced in the compound eye. Possibly a co-repressor like gro prevents
expression driven by 4xsoAE in the ocellar region. When soAE is combined with 
so10, this co-repressor might be displaced by the formation of a protein complex of 
SO, EYA and TOY and probably other factors. Therefore it will be interesting to 
investigate whether such a complex is formed indeed on so7 and so10-soAE. 
3.4.2. so directly regulates ey in eye development 
Positioned high up in the hierarchy of the retinal determination network, ey is a potent
inducer of ectopic eyes and is able to directly induce so and eya. Like ey, so and eya
are able to induce ectopic eyes when coexpressed, so alone fails to induce ectopic eyes. 
To accomplish this induction, eya and so need to feed back on ey, obviously by 
binding to the eye specific enhancer of ey. In an ectopic situation, the feedback of 
so/eya on ey is strong enough to induce ey for ectopic eye formation.
The function of this feedback-loop in normal eye development remains to be 
elucidated. so and eya are both expressed posterior to the furrow and are important for 
neuronal development (Pignoni et al., 1997). Nevertheless, ey expression was not 
detected posterior to the MF. The activity of the so site in the ey gene might therefore 
be suppressed by other factors or by so itself in this region. As coexpression of ey, so
and eya only is eminent in a few cells in front of the MF and within the MF, a possible 
role for this feedack-loop might be to boost ey expression in front of and within the
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furrow that consequently leads to a strengthening of so and eya expression in just a 
few cell rows.
For proper eye development, a well balanced expression level of the genes belonging 
to the retinal determination network is crucial. Loss of function mutations as well as 
overexpression of the eye specification genes ey, eya, so or dac during eye
development impedes proper determination of the organ and results in reduction of the 
eye size (Halder et al., 1998a; Curtiss and Mlodzik, 2000). Therefore we further 
hypothesize a feedback-loop of so on ey to be also important for the fine tuning of ey
expression during normal eye development. Due to its ability to activate as well as to 
repress the expression of genes, so is a potent regulator in this context. 
3.4.3. Linking the genetic cascade to signal transduction: so and hh
dpp signaling plays an important role in the complex regulatory network of eye
development. In dpp mutant eye discs, eya, so and dac signal is absent (Chen et al.,
1999), whereas dpp is able to initiate ectopic expression of so and dac when expressed
at the anterior margin of the eye disc (Chanut and Heberlein, 1997; Pignoni and 
Zipursky, 1997). Conversely, dpp expression is patchy in eye discs of eya and so loss-
of-function mutants, suggesting that eya and so are required for either initiation or 
maintenance of dpp at the posterior disc-margin prior to MF initiation (Pignoni et al., 
1997; Hazelett et al., 1998).
hh is required for dpp expression at the posterior margin prior to MF initiation (Borod
and Heberlein, 1998) and dpp expression is induced by hh in the MF (Heberlein et al.,
1993) supporting the assumption that dpp is downstream of hh signaling. Since dpp
alone is not able to rescue posterior margin clones of hh, there have to be more eye-
relevant target genes of hh signaling during 3rd instar larval development. dpp in
combination with eya can restore photoreceptor differentiation in posterior margin
clones lacking smoothened (smo) expression (smo is a cell-autonomous receptor of hh
signaling). This proves that dpp in combination with eya is able to bypass the 
requirement of hh during eye development (Pappu et al., 2003). Taken together, it is 
evident that hh is necessary for proper eya and dpp expression both of which can 
induce so and it contains two so target sites. We therefore hypothesized that the 
transcriptional complex consisting of EYA and SO, like on ey, might feed back on hh
as well in order to drive the furrow during late eye development. In this model the 
genetic cascade starts with hh that induces dpp and eya, moves on to so and by the 
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complex SO/EYA feeds back to hh in order to maintain hh expression as a driving 
force of the MF. 
The impact of these so binding sites in the hh enhancer on eye development becomes 
evident from the fact that bar-3 mutant flies have smaller eyes. The severity of the bar-
3 mutant phenotype probably is diminished by an additional putative SO binding site
that resides outside of the area that is covered by the bar-3 deletion (Fig. 6A SO 
binding motifs). If functional, this region (5’ to the bar-3 deletion) might mediate a 
residual hh-expression that overcomes the loss of the other sites to some extent. 
Another possible explanation for the rather weak phenotype of bar-3 might be the
assumption that the feedback of so on hh is not crucial for MF initiation but still might
be of importance for the well balanced expression of hh during MF propagation. 
3.4.4. A general theme of Six-gene target sites
so belongs to the Six gene family. All Six proteins are characterized by a Six-domain
(SD) and a Six-type homeodomain (HD), both of which are essential for specific DNA
binding and protein-protein interaction. Based on the amino acid sequence of their HD 
and SD the Six genes were divided into three subgroups. Each of the three Drosophila
homologs can be assigned to one of these subgroups: so is mostly related to Six1/2,
optix to Six3/6 and DSix4 to Six4/5 (for review see Kawakami et al.) (Kawakami and 
Kobayashi, 1998).
Promoter analyses of the mouse Six-genes (Six1/2, Six4/5) revealed similar target
sequence specificities for these mammalian counterparts of so. Six2, Six4/AREC3 and 
Six5 effectively bind to the same target sequence in a DNA fragment called ARE
(Atpla1 regulatory element) that can be found in the Na,K-ATPase ?1 subunit gene
(Fig. 4C, ARE fragment) (Suzuki-Yagawa et al., 1992; Kawakami et al., 1996a; 
Kawakami et al., 1996b; Harris et al., 2000). Six1 and Six4 have been shown to bind to 
MEF3 sites in the myogenin and in the aldolase A muscle-specific (pM) promoters
(Fig. 4C, MEF3 site) (Spitz et al., 1998). Recently, mammalian Six4 has been shown to 
additionally bind to the transcriptional regulatory element X (TreX) within the Muscle
creatine kinase (MCK) enhancer (Fig 4C, Trex) (Himeda et al., 2004).
Comparison of all these sites confirmed the three nucleotides, that we describe to be 
most important for SO-DNA interaction, to be present and conserved within these
motifs (nt. 1, 4 and 9 in Fig. 4C).
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In case of the MEF3 site which comprises 7 nucleotides that include only two of the 
nucleotides important for SO-DNA interaction (nt. 4 and 9 in Fig. 4C), we looked up 
the original publications to check for the third conserved nucleotide to be also present, 
and in most of the cases were able to verify its conservation. In fact, there is only one
exception published in a study that describes two Six2 target sites (Brodbeck et al., 
2004). Taking into account that SO has been shown to also bind (C/G)GATA in vitro
and that SO/EYA is able to activate a reporter by acting on the mutated oligomerized
soAE sites in S2 cells, it seems that sequences differing slightly from the perfect
binding sequence might still be sufficient to establish protein-DNA interaction to some
extent. In case of such sequences being clustered, they might still be able to have a 
biological function. We therefore can not exclude that sequences differing from our
consensus, even affecting one of the crucial nucleotides, might still respond to Six-
genes.
Nevertheless, by combining the vast majority of previous studies describing protein-
DNA interaction of Six genes and our study about SO-DNA interaction, we infer that 
SO, Six1, Six2, Six4 and Six5 have very similar properties in binding DNA. In the case
of so, we propose that the consensus sequence GTAANYNGANAY(C/G) marks a 
good starting point for finding additional targets of so and thereby helps to get more
insight into the complex genetic interactions that orchestrate the development of the 
visual systems of Drosophila.
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Figure 1. Defining a minimal version of so7 important for ocelli specific so expression
(A) Genomic map of the last intron of the so locus between exon6 (E6) and exon7 (E7) (black boxes).
The physical mapping is indicated as A=AseI, S=SspI, E=EcorI, K=KpnI.
An enlargement of the region deleted in so1 shows relative positions of the enhancer fragments so7, so10
and so9. so10 contains EY/TOY and TOY specific binding sites (black boxes and black triangles,
respectively). So9 harbours the SO-binding site.
The deletion map illustrates the constructs that where tested for the expression pattern they mediate (X
indicates introduced mutations). 27bp fused to so10 (Nr. 14) are sufficient to resemble the so7 mediated
pattern including ocelli-expression (B, referred to as +++ expression in ocelli and +++ expression in
compound eye). Constructs including so10 but missing the sequence represented by Nr21 just resemble
the so10-pattern and show no expression in the ocellar region (C). Constructs that are devoid of
functional EY and TOY sites (Nr17, 18, 19 and 21) but include the 27bp of Nr21 show an expression
pattern identical to so9 (D, illustrated by the pattern mediated by Nr.21). Fragment Nr21 is sufficient to
recapitulate the expression pattern of so9. It is referred to as soAE in the following. Construct Nr.20 (no
so10 and no Nr.21) does not mediate any expression at all (-).
(B-E) Arrows indicate the ocellar region. (B) Expression pattern mediated by Nr.14, similar to wt so
expression pattern and the so7 mediated pattern. (C) so10-LacZ: resembling wt-expression despite the
ocellar signal. (D) Nr.21-LacZ: expressing only along the posterior margin of the eye disc similar to so9-
LacZ. (E) So7mut: so7 where the SO-binding site is mutated mediates only weak expression to the
ocellar region (Fragment Nr. 22).
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Figure 2. soAE is a direct target of so
soAE corresponds to fragment Nr.21 (sine oculis autoregulatory element). Arrows indicate the ocellar
region.
(A-C) soAE harbours three putative transcription factor binding sites which have been mutated. (A)
Mutating the core of the HD recognition sequence (mutHD) or (B) mutating the GATA sequence
(mutGATA) abolishes expression of the LacZ reporter in the ocellar region. (C) so10-mutPAX in which
the putative Pax6 binding site is mutated, mediates expression indistinguishable from wt / so10-soAE-
mediated expression.
(D-F) Oligomerization of soAE boosts its expression. In contrast to soAE alone, which only mediates
expression in the posterior margin of the eye disc (D), 4xsoAE drives expression in all cells posterior of
the MF, within the MF and in some cells in front of the MF, but not in the ocellar region (E). This
expression resembles wt so-expression despite the ocellar region. (F) 10xsoAE does not further amplify
expression intensity but results in a more blotchy type of expression pattern.
(G) Sequences of soAE and the mutated versions of it. Sequences TAA and GAT of soAE are important
for the ocellar specific expression of so10-soAE-LacZ.
(F) Radiolabelled probes of mutHD and mutGATA are not shifted by SO in EMSA. In contrast,
mutPAX is bound by SO and therefore shifted in EMSA.
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Figure 3. SO acts upon the soAE motif in vivo and in S2 cells.
(A-C) 4xsoAE is ectopically induced in wing discs by EYA and EYA+SO protein but not by SO protein
alone. (A) dpp-GAL4 driving UAS-so does not induce 4xsoAE-LacZ in wing discs. (B) Ectopic
expression of 4xsoAE-LacZ is induced in spots along the AP boundary by dpp-GAL4:UAS-eya. (C)
Coexpression of so enhances eya mediated reporter gene activity.
(D) Ocelli specific expression of so10-soAE is lost in so2 mutant flies (arrow). so2 is a regulatory mutant
that displays an ocelliless phenotype. (E) EYA protein is detectable in the ocellar region of so2 mutant
flies (arrow).
(F-I) so is necessary for soAE activation: In so3 clones, 4xsoAE-LacZ expression is lost although EYA
is present in the cells. Clones are delimited by a dashed line. (F) EYA expression is shown in red and
marks the non dying cells within the clone. (G) so3 clones are negatively marked by the absence of GFP
expression (in green). (H) 4xsoAE-LacZ reporter gene expression (blue) is lost in so-/--cells. (I) overlay
of G and H. 
(J) ?-galactosidase reporter assays in Drosophila S2 cells. Reporter plasmids containing the LacZ gene
under the control of different enhancer fragments were transfected into the cells. Cotransfection of so or
eya alone together with the 10xsoAE-LacZ reporter plasmid does not exceed basal activity (lane 2,3). In 
contrast, coexpression of so+eya with the 5xsoAE or 10xsoAE reporter, leads to a strong induction of ?-
galactosidase (lane 4,5). The mutated versions of the 5xsoAE reporter (5xmutHD, 5xmutGATA) still
show some amount of induction  when cotransfected with so+eya (lane 6,7). ?-galactosidase values
were normalized by cotransfecting 5ng of plasmid expressing luciferase as an internal standard. The
results represent an average ?-galactosidase activity taken from transfections done in triplicates (?
standart deviation) and are illustrated as the X-fold activation over the basal activity found for the
reporter plasmid alone.
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Figure 4. Identification of nucleotides important for SO-DNA (soAE) interaction.
(A) SO protein is shifted by soAE (SO + hot probe) in EMSA. Double stranded probes bearing a single
point mutation (6-22) or a stretch of mutations (2-5) were used as cold competitors (100x molar excess)
and compared to soAE (1) for their ability to compete for SO-binding. Nucleotides important for
protein-DNA interaction are highlighted in red (very important) and orange (important) according to
their competing potential. As a control, mock transfected reticulocyte lysate was incubated with p32
marked soAE (TNT mock). (B) DNA probes of sequences resembling soAE taken from other genes
were used as cold competitors as well. A sequences out of the eye specific enhancer of the ey gene is a 
strong competitor. The fragment loses its binding property when the GAT sequence is mutated to CCC 
(eyeless, eyeless mut). Out of the Lozenge gene, only one of the previously described SO binding sites
shows a strong competition potential in EMSA (Lz first, Lz second). Strong competing sequences are
also found in the first intron of the hh gene (hh first, hh second). SO binding is furthermore strongly
competed by the well described AREC3/Six4 binding site.
(C) Upper half: sequences of the probes that were used as cold competitors in Fig. 4B. Based on these
sequences and the results shown in (A) a consensus binding sequence for SO was proposed. Lower half:
Previously described binding sites for the vertebrate Six1,2,4,5. These sequences appear to be related to 
the SO binding sequence.
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igure 5 ey contains a functional SO binding site
(E2) and exon 3 (E3) (black boxes). The previously
he wt ey-enhancer fragment in a 3  instar eye imaginal disc.
the so-
ced to a spot in the center of the
F
(A) Genomic map of the ey locus between exon 2
described eye specific ey-enhancer is indicated by brackets. Relative positions of transposable elements
that interfere with eye development are indicated by their allelic name (eyR, ey2). The sequence of the 
eye specific ey enhancer is given below (ey enhancer). B4M: the putative Pax6 binding sites (boxed)
were mutated accordingly to Hauck et al. (Hauck et al., 1999) to get rid of toy-mediated signal. B4M
SOmut: the putative Pax6 binding sites and additionally the putative SO-binding site (grey shaded) were
mutated for comparison to B4M.
(B) LacZ expression mediated by t rd
(C) B4M-LacZ expression: without an influence of TOY protein, due to the mutated sites,
mediated expression is restricted to a portion of the posterior margin.
(D) B4M SOmut-LacZ: Mutating also the so-site, expression is redu
posterior margin.
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igure 6 hh contains functional SO binding sites
apping is indicated as X=XhoI, S=SacI, K=KpnI. The
diated by 1.4kb genomic DNA from the region
ut: Expression is hardly detectable when the two SO binding sites are mutated. (hh
ct containing only one mutated SO
F
(A) Genomic map of the hh locus. The physical m
bar-3 deletion is mapped according to Lee et al. (Lee et al., 1992). Two SO binding sites are located
within the region deleted in bar-3 (Sequences are given in Fig. 4C: hh first, hh second). One additional 
SO binding site is found upstream of the bar-3 deletion.
(B) hh bar-3: LacZ expression posterior to the MF is me
deleted in bar-3.
(C) hh bar-3 SOm
first: GAG is changed to CCC, hh second: GAT is changed to CCC) 
(D) hh bar-3 ?5’: No expression is detected from a reporter constru
binding site. 
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3.5. Experimental Procedures
3.5.1. Fly strains and histology 
Flies were reared on standard medium at 25°C. Lines used: UAS-so (Pignoni et al.,
1997), UAS-eya (Bonini et al., 1997), so10-LacZ (Niimi et al., 1999), so7-LacZ, so9-
LacZ, so10EY+TOYmt-LacZ (Punzo et al., 2001), dppblink-GAL4 (Staehling-Hampton and 
Hoffmann, 1994), ey-GAL4 (Halder et al., 1998a), FRT42D, so3/CyO (Pignoni et al., 
1997). eyFLP (Newsome et al., 2000). FRT42D, ubiquitinGFP (Duchek et al., 2001). 
so2/so2 (Bloomington Stock centre). Clones of homozygous so3 mutant cells were
generated by the expression of FLP recombinase under the control of an ey enhancer. 
Specific genotypes generated: (1) eyFLP; FRT42D, ubiquitinGFP (2) so2/so2; so10-
soAE-LacZ (3) so2/so2; so7-LacZ (4) UAS-so/UAS-so ;UAS-eya/UAS-eya
LacZ reporter plasmids were introduced into w1118 by standard P-element
transformation procedures. Three to ten independent transgenic lines were established 
for each construct and tested for expression.
Antibody staining on discs was performed according to Halder et al. (Halder et al., 
1998a). Primary antibodies were anti-EyaMab10H6, 1:10 (Bonini et al., 1997), Rabbit 
anit-?-Galactosidase, 1:500 (Promega). Secondary antibodies used were from Jackson 
ImmunoResearch Laboratories: Cy5 ?-rabbit (1:400), Alexa586 ?-mouse (1:400). 
To detect ?-galactosidase activity, 3rd instar larval imaginal discs were fixed and
subjected to a standard X-gal color reaction for 2 hours at 37°C.
3.5.2. Reporter Transgenes 
Inserts of the reporter constructs were obtained by PCR, using so7 as a template, and 
subcloned into the LacZ pC? vector (Niimi et al., 1999).
For the constructs: ey enhancer, B4M and B4M SOmut, the sequences given in Fig. 5 
were used.  A BamHI and a KpnI site was added at the 5’ and 3’-end, respectively, and 
used for subcloning into the LacZ pC? vector.
The hh bar-3 sequence was obtained by PCR on genomic DNA of wt flies by using the 
following primer set: 5’-CTGTGCGCTCGAGTGGGCCACACAGGGTGGG-3’;
rightward orientation, 5’-CGGCCCGTCTCAGATCTCGGATCTGAGATC-3’
leftward orientation. Mutations were introduced by PCR. For the deletion construct hh
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bar-3 ?5’, 5’-GGGGTACCCAAGACAAGTAATCCCCCACCCTCGC-3’ was used
as rightward orientaded primer (the SO site is mutated by changing GAG toCCC). 
3.5.3. so2 mutant
Genomic DNA was amplified by PCR from so2/so2 flies and sequenced. The 
sequences were confirmed on independent amplification events. Genomic DNA 
isolation was performed according to Bui et al (Bui et al., 2000a). Primers used for
mapping the so2 deletion were: 5’-GAAGGGCACTGCTTACTGAGAGCTCG-3’, 5’-
GCCCATCGAATCCGCATCTCCCCCAG-3’ rightward orientation; 5’-
GCGCACACTCGACAAATTTGCGATCTGGC-3’ leftward orientation,
Primers are located at positions 2355, 3116, 6218 respectively within the last intron.
Nuclotides 3983-5181 are deleted in so2 ( the first nt of the last intron is set as 1). 
Southern blotting was performed according to Sambrook et al. (Sambrook and Russel, 
2001). Genomic DNA was digested using ClaI, EcorV and XhoI. As probes, DIG 
labeled PCR products of so10 and so9 were used. so10 and so9 are described 
previously (Punzo et al., 2002). 
3.5.4. Transfections and Reporter Gene Assays 
Drosophila S2 cells were maintained in Schneider’s insect medium (Invitrogen) 
supplemented with 10% Fetal Calf Serum and were transfected with the Effectene 
Transfection Reagent (Qiagen). For reporter gene assays 2 x 106 cells were transfected 
with a total of 200 ng plasmid DNA (20 ng reporter plasmid, 5 ng of a plasmid 
constitutively expressing firefly luciferase, the indicated amounts of expression 
plasmids and the parental vector pAc5.1B/V5His to bring the total amount of DNA to
200 ng). Cells were lysated 48h after transfection and lysates were assayed for ?-
Galactosidase and luciferase activity as described previously (Muller et al., 2003). 
3.5.5. Electrophoretic Mobility Shift Assays (EMSA) 
Radioactive labeled probes were generated by annealing and filling in partially
overlapping oligonucleotides in the presence of (?-32P)ATP. Binding reactions were 
carried out in 20 ?l of 100 mM KCl, 20mM HEPES pH7.9, 20% glycerol, 1mM DTT,
0.3% BSA, 0.01% NP40 containing 10000 cpm probe and 1 ?g dIdC. As a protein 
source, full-length SO protein was synthesized in reticulocyte lysates using the T7 
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promotor according to the manufacturer specification (Promega). For the binding
reaction, 1 ?l of a standard 50 ?l reaction was used. After incubation for 30 min at 
4°C, the reactions were analyzed by non-denaturing 6% polyacrylamide gel
electrophoresis followed by autoradiography. For the cold competition experiments,
the proteins were first incubated with a 100x molar excess of unlabeled doublestrand 
oligonucleotides for 10 min. at RT, followed by incubation with the radiolabeled probe
at 4°C for 30min.
3.5.6. Computer-assisted search for SO binding sites 
Putative so-target-genes were identified by screening the entire Drosophila genomic
sequence with the consensus GTAANYNGANAYS using the program FLY 
ENHANCER (freely available at http://flyenhancer.org (Markstein et al., 2002)). 
Alignements of different Drosophila species were obtained from:
http://hanuman.math.berkeley.edu/genomes/drosophila.html
We are grateful to F. Pignoni, B. Dickson and P. Rorth for fly stocks. We would like to 
thank C.Brink for critical comments on the manuscript. T.P. was supported by a
MD/PhD Grant from the Fondation suisse de recherche sur les maladies musculaires
(FSRMM).
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3.6. Appendix 
Figure A1 soAE within so7 
Alignment of 7 Drosophila species. The sequence presented covers soAE (boxed in red) and adjacent
sequences within the so7 enhancer fragment of the so locus. The most important nucleotides of SO-
DNA interaction are shown in red.
Figure A2 Putative SO binding site of the eye specific enhancer of the eyeless gene.
Alignment of 7 Drosophila species. The most important NTs of SO-DNA interaction are shown in red.
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igure A3 The two putative SO target sites within the hh locus
SO-DNA interaction are shown in red.
ll alignments of the Appendix are based on the freely available online tool at: 
F
Alignment of 7 Drosophila species. The most important NTs of
The first putative SO target site is in reverse direction.
A
http://hanuman.math.berkeley.edu/genomes/drosophila.html
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   Abteilung Zellbiologie
   Klingelbergstrasse 70
   4056 Basel
e-mail:   T.Pauli@unibas.ch 
Ausbildung
1978 – 1983 Primarschule Mairiacker, Binningen BL 
1983 – 1987 Progymnasium Spiegelfeld, Bottmingen BL 
1987 – 1991 Gymnasium, Oberwil BL 
1991   Matura Typ C
1992 – 1994 Physikstudium an der Universität Basel 
1994 Vordiplom in Physik
1994 – 2000 Medizinstudium an der Universität Basel 
2000   Diplom für Ärzte
2001 – 2004 MD/PhD unter der Leitung von Prof. W. J. Gehring am 
Biozentrum in Basel 
2004   Promotion in Medizin
2004   Promotion in Zellbiologie
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